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Chapter 1. 
 
Introduction and Background 
 1
 Motoneuron loss is a significant medical problem, and can result from disease 
processes or from traumatic injuries. For example, amyotrophic lateral sclerosis (ALS) is 
a fatal disease characterized by the rapidly progressive loss of motoneurons, affecting 2-3 
people per 100,000 population per year, with over 6000 new diagnoses made every year 
in the United States alone. While ALS is the most prevalent, other diseases are also 
characterized by progressive loss of motoneurons, including the motor neuron diseases 
(MNDs) and spinal muscular atrophies (SMAs). Traumatic spinal cord injuries are even 
more prevalent: in the United States, more than 10,000 people per year survive a spinal 
cord injury. Of these, around 45% suffer from spinal motoneuron lesions, and this 
number rises to around 95% for those with lumbar or sacral injuries (Doherty et al., 
2002). 
 Many treatment strategies have been developed to enhance neuronal survival and 
regeneration in disease and following traumatic injuries (Tsai and Tator, 2005). Some of 
these involve macro-scale physical changes in the environment of the injury or diseased 
tissue, such as by the grafting of peripheral nerve sheaths (e.g., Storer et al., 2002) or the 
transplantation of supportive cells (Xiang et al., 2005). The observation that these kinds 
of treatments also produce molecular-level changes to the environment has led to 
attempts at treating injured or diseased tissue directly with various regeneration 
associated molecules (Makwana and Raivich, 2005). By far, the class of molecules that 
has received the most attention in this capacity is the neurotrophic factors; and in fact, 
neurotrophic factors appear to have dramatic effects in preventing neuron death and 
promoting neuron regeneration (e.g., Blits et al., 2004; Clatterbuck et al., 1994; Kishino 
et al., 1997; Novikov et al., 2000; Wu et al., 2003; Yang and Arnold, 2000b; Yang et al., 
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2004). The principal drawback of using neurotrophic factors therapeutically is that most 
of them will not cross the blood-brain barrier, meaning that they have limited efficacy 
when simply administered systemically (Wu, 2005). 
 Gonadal steroids also exhibit a wide array of neuroprotective and 
neurotherapeutic effects, and in contrast to neurotrophic factors, readily cross the blood-
brain barrier and (Henderson and Reynolds, 2002; Jones, 1993; Jones et al., 2001; 
Woolley and Cohen, 2002). For example, testosterone treatment accelerates both axon 
regeneration and functional recovery following axotomy of spinal or cranial motoneurons 
(Jones et al., 2001). After crush axotomy of hamster facial motoneurons, treatment with 
exogenous testosterone accelerates the recovery of motor function (Kujawa and Jones, 
1990; Kujawa et al., 1989); this effect appears to be due to an acceleration in the rate of 
facial motoneuron axon regeneration, which is also increased with exogenous 
testosterone treatment (Kujawa et al., 1991). Interestingly, the timing of testosterone 
treatment is critical, as only immediate treatment with testosterone has been shown to 
accelerate functional recovery or axon regeneration (Kujawa et al., 1991; Kujawa and 
Jones, 1990; Tanzer et al., 2000; Tanzer and Jones, 2004), and longer treatment times 
result in greater accelerations (Kujawa et al., 1991; Tanzer et al., 2000). 
 I have begun to extend findings of the neuroprotective/neurotherapeutic effects of 
testosterone to dendrites. The dendritic arbor is the most striking morphological feature 
of many neurons, accounting for up to 97% of the surface area of a neuron (Cameron et 
al., 1985), and accommodating up to 100,000 synaptic contacts (Burke, 1990; Ulfhake 
and Cullheim, 1988). Dendritic morphology is intimately connected to neuronal identity 
and function. For example, motoneurons innervating different muscles have distinct 
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dendritic morphologies (Cameron et al., 1985; Cullheim et al., 1987b; Furicchia and 
Goshgarian, 1987; Ritz et al., 1992; Schoenen, 1982; Ulfhake and Kellerth, 1981), and 
within a muscle motoneurons innervating fast vs. slow muscle fibers are associated with 
different dendritic morphologies (Cullheim et al., 1987a). Dendritic structure is also tied 
to the electrophysiological response properties of neurons. Differences in morphology are 
reflected electrophysiologically, even between different types of neurons within a 
particular structure (Grudt and Perl, 2002; Lu et al., 2001; Rumberger et al., 1998); and 
dendritic morphology has a direct effect on the electrophysiological responses of the cell 
(Mainen and Sejnowski, 1996; Vetter et al., 2001). 
 Several forms of neural injury are known to impact neuronal morphology, 
including deafferentation and axotomy. Deafferentation often results in dendritic 
retraction and atrophy of deafferented neurons (e.g., Brown et al., 1979; Caceres and 
Steward, 1983; Somogyi et al., 1987; Wellman and Sengelaub, 1995). However, 
deafferentation of motoneurons has also been shown to result in several other 
morphological responses, including biphasic expansion and retraction of dendrites 
(Bernstein and Standler, 1983) and the development of distinct size classes in previously 
homogeneous populations (Bernstein et al., 1984), and even appears to be permissive of 
dendritic growth in certain cases (Bury et al., 2000; Jones and Schallert, 1994). Most 
studies of the effects of axotomy on neuronal morphology have also reported dendritic 
atrophy (e.g., Brännström et al., 1992; Naumann et al., 1992; O'Hanlon and Lowrie, 
1995; Sumner and Watson, 1971; Yawo, 1987; but see Rose and Odlozinski, 1998). 
However, this is not the only response reported; for example, Standler and Bernstein 
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(1982) described a cyclic pattern of repeated degeneration and regeneration of the 
dendritic arbor following crush axotomy. 
 I have been examining the therapeutic effects of testosterone on dendritic 
morphology in an injury model using the spinal nucleus of the bulbocavernosus [SNB; 
also known as the dorsomedial nucleus or DM (Schrøder, 1980); see Figure 1.1]. The 
SNB is a small, discrete, well-characterized population of sexually dimorphic 
motoneurons located in the lumbar spinal cord of the rat. The SNB is bilaterally 
organized, and in males, motoneurons from each half of the nucleus innervate the 
ipsilateral bulbocavernosus (BC) and levator ani (LA) muscles (BC/LA), as well as the 
external anal sphincter (Breedlove and Arnold, 1980; McKenna and Nadelhaft, 1986; 
Schrøder, 1980). This neuromuscular system is involved in erectile functions and is 
critically important for male sexual behavior (Hart and Melese-D'Hospital, 1983; Sachs, 
1982). 
 The large somata of SNB motoneurons support broad dendritic arbors which 
extend throughout a large volume of the surrounding neuropil (Kurz et al., 1986). Owing 
to their medial location, this creates a large region of bilateral dendritic overlap 
(Goldstein et al., 1993; Kurz et al., 1986; Rose and Collins, 1985; see Figure 1.2). Both 
SNB motoneurons and their target muscles are sensitive to testosterone manipulations 
(Breedlove and Arnold, 1981; Kurz et al., 1986; Matsumoto, 1997; Wainman and 
Shipounoff, 1941). Androgens maintain a wide variety of SNB motoneuron 
characteristics, including the morphology of somata (Breedlove and Arnold, 1981) and 
dendrites (Kurz et al., 1986), the number and size of gap junction plaques (Matsumoto et 
al., 1988), actin and tubulin mRNA expression (Matsumoto et al., 1993; Matsumoto et  
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FIGURE 1.1 
Schematic representation of the spinal nucleus of the bulbocavernosus (SNB) and its 
projections to the muscles of the perineum in the male rat. Note the medial placement of 
the nucleus within the spinal cord. Although it is not clear in this graphic, individual SNB 
motoneurons can project to either the BC or the LA, but not both. 
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FIGURE 1.2 
Camera lucida reconstruction of a single left-side SNB motoneuron after intracellular fill 
with HRP. Arrow indicates axon. 
Inset: location of this motoneuron within the lumbosacral spinal cord. Arrowhead 
indicates midline. Note the prominent arborization of dendrites across the midline. 
From Sasaki and Arnold (1991). 
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al., 1992; Matsumoto et al., 1994), and levels of synaptic input (Leedy et al., 1987; 
Matsumoto et al., 1988). Testosterone also modulates several important biochemicals in 
the SNB, including ciliary neurotrophic factor receptor α (Forger et al., 1998), calcitonin 
gene-related peptide (Monks et al., 1999; Popper and Micevych, 1989; Popper and 
Micevych, 1990), N-cadherin (Monks et al., 2001; Monks and Watson, 2001), Bcl-2 (Zup 
and Forger, 2002), and BDNF (Yang et al., 2004). These features make the SNB an 
excellent system in which to study the therapeutic effects of testosterone on dendritic 
morphology following injury. The SNB is also particularly exciting as a model system 
from a clinical perspective. Approximately 80% of spinal cord injury patients are male, 
and 60% are under 30 years old, making the effects of injury to the male perineal 
neuromuscular system especially relevant. 
 Lesions of the CNS typically result in cell death in affected neuronal populations. 
Additionally, neuron loss can lead to morphological changes in other neuronal 
populations related by proximity and/or connectivity (e.g., Fargo and Sengelaub, 2004a, 
2004b; Wellman and Sengelaub, 1991, 1995). Presumably, some loss of motor function 
after injury is mediated by this secondary cellular atrophy. Additionally, absent the ability 
to replace dead neurons, surviving motoneurons must be the basis for recovering function 
lost due to the primary cell death. Therefore, learning how to prevent or reverse neuronal 
atrophy secondary to neuron depletion is an important goal. This forms the rationale for 
this dissertation. 
Previous Studies 
 I have conducted two previous studies relevant to the present thesis. In the first 
(Fargo and Sengelaub, 2004a), I showed that unilateral motoneuron depletion leads to 
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atrophy of motoneurons on the contralateral side of the spinal cord. Moreover, I showed 
that testosterone treatment protected motoneurons from that atrophy, thus demonstrating 
a neuroprotective effect of testosterone in a motoneuron injury model. To induce 
unilateral motoneuron death, I injected a toxin consisting of saporin conjugated to cholera 
toxin B subunit (CTB-saporin) into the right BC and LA muscles of adult male Sprague 
Dawley rats. When injected into the perineal muscles, CTB-saporin interacts with GM1 
ganglioside (Abe and Norton, 1974) on SNB nerve terminals, causing the neurons to 
endocytose the toxin, which is then retrogradely transported to their somata in the spinal 
cord. Saporin is a type 1 ribosome inactivating protein; it irreversibly inactivates 
ribosomes, thereby halting protein synthesis and leading to cell death (Bergamaschi et al., 
1996; Stirpe, 2004; Stirpe et al., 1992; Stirpe et al., 1983). CTB-saporin has previously 
been used to kill sympathetic preganglionic neurons after injection into the superior 
cervical ganglion (Llewellyn-Smith et al., 1999) and facial motoneurons after injection 
into the facial nerve (Llewellyn-Smith et al., 2000). Unilateral CTB-saporin injection into 
the perineal musculature results in laterally specific motoneuron depletion: approximately 
60% of SNB motoneurons ipsilateral to the injected muscle die, while the number of 
motoneurons contralateral to the injection remains unchanged. Some animals treated with 
CTB-saporin also underwent a testosterone manipulation. They were castrated 6 weeks 
prior to injection with CTB-saporin, then at the time of injection were given 
subcutaneous testosterone-filled Silastic implants designed to produce plasma 
testosterone titers in the high-normal physiological range (3.18 mm outer diameter, 1.57 
mm inner diameter, 45 mm long; Smith et al., 1977). 
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 Four weeks later, I prepared the contralateral SNB motoneurons for visualization. 
I injected HRP conjugated to the cholera toxin B subunit (CTB-HRP; a retrogradely 
transported tracer) into the left BC muscle. Two days later, animals were killed and spinal 
cords were removed and processed for CTB-HRP visualization with a modification of 
Mesulam’s (1982) tetramethyl-benzidine protocol. SNB motoneurons contralateral to the 
CTB-saporin injection were viewed under darkfield illumination, and reconstructed in 
three dimensions. Motoneuron depletion resulted in significant dendritic and somal 
atrophy in contralateral motoneurons. The effect was particularly large in dendrites, 
which lost over 60% of their normal length. However, testosterone treatment prevented 
this outcome for dendrites: animals injected with CTB-saporin and treated with 
testosterone had normal dendritic length. As SNB motoneurons are known to receive 
trophic support from their target muscles (al-Shamma and Arnold, 1995; Rand and 
Breedlove, 1995; Yang and Arnold, 2000a), it is worth noting that the BC and LA 
muscles were hypertrophied in testosterone-manipulated animals. It is therefore possible 
that testosterone acts at the target muscle, which then provides enough target support to 
the surviving motoneurons to overcome the effects of unilateral depletion. 
 The testosterone manipulation in this study was relatively complex, and left room 
for several possible interpretations as to which aspect of the manipulation was protecting 
dendritic morphology. The protective element might have been the castration-induced 
state of regression the SNB motoneurons were in at the time of the CTB-saporin 
injections, the active regrowth process induced in the SNBs of castrated animals by 
testosterone reintroduction, or the high-normal systemic levels of testosterone produced 
by the implants. 
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 This issue was resolved in the second study (Fargo and Sengelaub, 2004b). Three 
groups of animals were compared: normal controls, animals given unilateral 
intramuscular injections of CTB-saporin, and animals both injected with CTB-saporin 
and treated with exogenous testosterone. However, the testosterone treatment differed 
from the previous study: testosterone-treated animals were both castrated and given 
testosterone implants simultaneously on the day on CTB-saporin injection. This design 
eliminates the possibility that motoneuron morphology could be affected by either the 
regression caused by castration or the regrowth caused by testosterone reintroduction. 
Consistent with the results of our first study (Fargo and Sengelaub, 2004a), the dendrites 
of testosterone-treated males were of normal length despite injection with CTB-saporin. 
Thus, the protective effect of testosterone treatment following unilateral motoneuron 
depletion is not dependent on castration-induced regression or the active regrowth caused 
by delayed testosterone reintroduction. Instead, the exogenous testosterone itself has a 
protective effect. As in the previous study, the BC and LA muscles of testosterone-treated 
animals were hypertrophied. 
 These studies present an intriguing possibility. For the reasons outlined in the 
background section, the SNB is an especially appealing system in which to study the 
functional and morphological effects of neuronal depletion and testosterone treatment. It 
is possible that these studies could form the basis of a model preparation with which to 
examine these phenomena. Several important basic questions need to be answered about 
the effects observed in these studies: 1) can similar effects of depletion and testosterone 
treatment can be demonstrated between motoneuron groups innervating muscles on the 
same side of the body; 2) does motoneuron depletion affect the electrophysiological 
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response properties of contralateral SNB motoneurons, and can testosterone treatment 
restore them to normal; 3) do the effects of CTB-saporin injection depend on a direct 
effect of the exogenous toxin; and 4) can the protective effect of testosterone be due the 
activity of its estrogenic metabolite? These questions form the basis of the experiments in 
this dissertation. 
Organization of the Thesis 
 The thesis is divided into seven chapters. In this first chapter, I introduce the 
background and significance of the dissertation work, including my previous studies that 
form the basis for the dissertation. Several methods and techniques are used in more than 
one experiment in the dissertation; in the second chapter I describe these in detail and 
justify their use. Chapters 3 through 6 form the bulk of the thesis. In these chapters I 
describe the individual experiments that form the dissertation. In each chapter I give the 
rationale for the experiment, explain the experimental design (including explaining and 
justifying divergences from the common techniques described in Chapter 2), describe the 
results of the experiment, and interpret and discuss those results. In Chapter 7, I discuss 
broadly the significance of the major findings of the dissertation. 
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Chapter 2. 
 
Experimental Methods and Techniques 
 13
 Several of the methods and techniques in this dissertation are used in more than 
one experiment. Instead of describing them and the justifications for their use in multiple 
chapters, I will describe them and explain the general reasons for their use here. In 
subsequent chapters I will refer back to these descriptions. In cases where these 
techniques have special implications for a specific experiment, I will explain those in the 
chapter containing that experiment. 
Animals 
 All animals were adult male Sprague Dawley rats obtained from Harlan 
(Indianapolis, Indiana), and were approximately 100 days old at the beginning of each 
experiment. Animals were maintained on a 12:12-hour light:dark cycle, with ad libitum 
access to food and water. 
Saporin Injection 
 Saporin is a type 1 ribosome inactivating protein derived from the plant saponaria 
officinalis, commonly known as soapwort (Stirpe et al., 1983). Ribosome inactivating 
proteins work by irreversibly inactivating ribosomes, thereby halting protein synthesis 
and leading to cell death. On its own, however, saporin is relatively innocuous, as it is 
almost completely incapable of crossing cell membranes to enter cells (Stirpe, 2004). 
When conjugated to other molecules, though, saporin can be used as a very effective 
targeted toxin. Typically, saporin is conjugated to another molecule that confers upon it 
the ability to enter a specific class of cells, usually a cell that expresses a receptor for the 
conjugated molecule, while bypassing other cell types (Lappi and Wiley, 2004). In the 
current experiments, I use a form of saporin conjugated to the B subunit of cholera toxin 
and mixed with distilled water to produce a 0.1% (w/v) solution. This form of saporin is 
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commonly referred to as CTB-saporin. CTB-saporin enters cells that express the cell 
surface ganglioside GM1. In the perineal musculature, the nerve terminals of SNB 
motoneurons express GM1, so CTB-saporin injected into the perineal muscles is actively 
endocytosed by SNB motoneurons. This method results in the death of approximately 
60% of the SNB motoneurons ipsilateral to the injected muscles, but none of the 
contralateral SNB motoneurons. The principal advantages of intramuscular injection of 
CTB-saporin are that it kills motoneurons a) in a muscle-specific manner, and b) without 
the complications of mechanical injury to the surrounding neuropil. 
 Animals were placed under general anesthesia by putting them in an induction 
chamber containing ether-soaked cotton pads until they no longer responded to deep pain. 
Animals were then placed in the supine position, and a cone containing ether-soaked 
cotton pads placed adjacent to their snouts in order to maintain areflexia to noxious 
stimuli. A midline incision was then made in the ventral scrotal wall, and blunt dissection 
was performed to expose the right side BC/LA muscle complex. I then injected a 1 µl 
bolus of 0.1% saporin solution into the belly of the right BC muscle using a 10 µl 
Hamilton syringe. In order to minimize leakage, the syringe was slowly and carefully 
withdrawn after the injection. I then repeated this procedure to inject another 1 µl of the 
saporin solution into the right LA muscle. This exposes most of the motoneurons in the 
ipsilateral SNB to the toxin (presumably, most of the SNB motoneurons that survive this 
procedure project to the external anal sphincter). The scrotum was then closed with 9-mm 
AutoClips brand stainless steel wound clips (MikRon Precision, Inc.; Gardena, CA), and 
after any other surgical procedures were completed, the animal was allowed to recover 
from anesthesia. 
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Castration 
 Animals were placed under general anesthesia by putting them in an induction 
chamber containing ether-soaked cotton pads until they no longer responded to deep pain. 
Animals were then placed in the supine position, and a cone containing ether-soaked 
cotton pads placed adjacent to their snouts in order to maintain areflexia to noxious 
stimuli. A small midline incision was then made in the ventral scrotal wall. Forceps were 
used to grasp a portion of the tunica immediately overlying the right cauda epididymidis, 
and a small portion of it was dissected away, creating an opening. The entire right testicle 
and epididymis were extruded through this opening, along with a length of the ductus 
deferens and as much of the adipose tissue of the spermatic cord as was possible without 
risking traumatic injury to the animal. A ligature of silk cord was then made around the 
ductus deferens and the blood vessels (and any remaining adipose tissue) of the spermatic 
cord, and these were cut distal to the ligature. The detached testicle, epididymis, and 
adipose tissue were discarded. The ligated ductus deferens and spermatic cord were then 
tucked back into the scrotum, and the process was repeated on the left side using the 
same incision in the scrotum. The scrotum was then closed, and after any additional 
surgical procedures appropriate to the experiment were performed, the animal was 
allowed to recover from anesthesia. 
 Castration is used to remove the body’s major source of circulating testosterone. 
(Although the adrenal gland does produce some testosterone, its amount is vanishingly 
small and its functional significance is negligible.) When used alone, the experimental 
purpose of castration is to determine the effect of removing testosterone from the model 
organism. When used in conjunction with hormone replacement (see below), the 
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experimental purpose is to reduce variability in testosterone levels, both between animals 
and within animals.1
Testosterone Implants 
 Testosterone replacement was given in the form of Silastic implants. Silastic 
implants were formed from 55-mm lengths of Silastic brand silicone tubing with a 1.57 
mm inner diameter and a 3.18 mm outer diameter (Dow Corning; Midland, MI). A 5 mm 
wooden dowel was lodged into one end of the Silastic tube. Using a custom made tamper, 
I then filled the tube with crystalline testosterone (4-androsten-17β-ol-3-one; Steraloids, 
Newport, RI), leaving 5 mm at the other end empty. Another 5 mm dowel was then 
lodged into the empty end. To remove testosterone from the outside of the implants, they 
were then cleaned with a Kimwipe (Kimberly-Clark, Neenah, WI) moistened with 
absolute ethanol. The ends were then sealed with Silastic brand silicone Type A medical 
adhesive (Dow Corning); one coat was applied and allowed to cure overnight, then a 
second coat was applied and allowed to cure until implantation (at least overnight). The 
finished implants had a length of 45 mm of testosterone apposed to the surface of the 
Silastic tubing. 
 Implantation was accomplished under ether anesthesia, in conjunction with either 
castration or saporin injection or both, as described above. After the other procedure or 
procedures were completed, the animal was placed in the prostrate position and a small 
incision was made into the skin between the scapulae. The implant was then placed under 
the skin through this incision. The incision was closed with 9-mm AutoClips brand 
stainless steel wound clips, and the animal was allowed to recover from anesthesia. 
                                                     
1 In intact adult male rats, testosterone levels fluctuate constantly throughout the day, ranging between 0.3 
and 8.9 ng/ml plasma (Södersten et al., 1983), with a daily average of 2.36 ± 0.25 (Mean ± SEM) ng/ml 
plasma (Damassa et al., 1977). 
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 Silastic silicone tubing is a permeable material, and testosterone passes through it 
at a constant rate. Thus, implants like these can be used to deliver relatively steady levels 
of testosterone to the body, and the amount of testosterone delivered can be controlled by 
varying the length of the implant. 45-mm implants, like those used in these experiments, 
produce levels of testosterone in the bloodstream toward the high end of the normal range 
(Smith et al., 1977). 
Visualization of Spinal Motoneurons 
 HRP injection 
 SNB motoneurons were retrogradely labeled for visualization with horseradish 
peroxidase (HRP) conjugated to the B subunit of cholera toxin. As mentioned in the 
section describing saporin injections above, the cholera toxin B subunit interacts with the 
GM1 ganglioside on the nerve terminals of SNB motoneurons to induce endocytosis of 
their conjugate. While free HRP is readily taken up by nerve terminals and transported to 
the somata and primary dendrites of motoneurons, HRP conjugated to cholera toxin B 
subunit provides a much more complete cellular fill and enables the visualization of even 
distal dendritic branches (for an example, see Figure 3.4); because of this, it has become 
the standard label used in anatomical studies of SNB motoneurons. In the current 
experiments, I use a form of HRP conjugated to the B subunit of cholera toxin and mixed 
with distilled water to produce a 0.2% (w/v) solution. This form of HRP is commonly 
referred to as CT-HRP, CTB-HRP, BHRP, or βHRP. However, for the sake of reabability 
I will refer to it throughout this thesis simply as HRP (when I refer to unconjugated HRP, 
I will specifically identify it as such). 
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 Previous experiments (Fargo and Sengelaub, 2004a, 2004b; Kurz et al., 1986) 
have established that two days is an optimal length of time to wait between HRP injection 
and sacrifice in the SNB/BC system, allowing for the visualization of cell bodies and 
distal processes; therefore HRP injection occurred two days prior to sacrifice. After 
placing the animals under ether anesthesia, injections proceeded as described above for 
saporin injections. However, there were two very important differences between saporin 
injections and HRP injections. First, HRP injections were made into only the BC muscle. 
The reason for this is that the vast majority of the previous literature on the anatomy of 
the somata and dendrites of SNB motoneurons have utilized BC-projecting motoneurons 
(e.g, Fargo and Sengelaub, 2004a, 2004b; Goldstein et al., 1993; Kurz et al., 1986; Yang 
et al., 2004). Therefore, in order to facilitate comparison with previous studies, I too used 
BC-projecting motoneurons as my model. The second important difference between the 
saporin injections and the HRP injections is that the HRP injections were made into the 
left side of the muscle complex. Note that this means that the motoneurons visualized for 
anatomical study are contralateral to the motoneurons that were killed by saporin 
injection. This is consistent with previous studies (Fargo and Sengelaub, 2004a, 2004b; 
Goldstein et al., 1993). Each animal received a 0.5 µl bolus of 0.2% HRP solution into 
the left side BC muscle. 
 Spinal cord removal and processing 
 Two days after HRP injection, animals were killed with an overdose of urethane. 
Animals were weighed and given an i.p. injection of urethane dissolved in distilled water 
for a total dose of 0.25 g urethane per 100 g body weight. If the animal did not reach 
areflexia to deep pain within approximately 10 to 15 minutes, an additional 1 ml i.p. 
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injection of the urethane solution was given. Rarely, an animal required yet another 1 ml 
i.p. injection to reach areflexia to deep pain. 
 Once animals reached the appropriate level of anesthesia, they were placed in the 
supine position and the skin was cut across the ventrum just caudal to the sternum. The 
abdominal wall was then lifted and cut just caudal to the sternum, with care taken to 
avoid damaging the liver. The diaphragm was then cut, with care taken to avoid 
damaging the heart or lungs. The ribcage was then cut along both sides and reflected to 
expose the heart. A cannula was placed in the left ventricle and the right atrium was cut. 
Animals were then perfused through the heart with saline solution fed by a gravity pump. 
This was followed by perfusion with cold fixative (1% paraformaldehyde/1.25% 
glutaraldehyde). 
 Animals were then placed in the prostrate position and an incision of 
approximately 10 cm was made into the skin of the back directly over the spine. The skin 
was then spread and a portion of the spinal column approximately 6 to 7 cm long and 
containing the points of articulation for the most caudal 3 to 4 ribs was removed. This 
portion of the spinal column was then trimmed until it contained the point of articulation 
of only the final rib and was only 3 to 4 cm long. This method reliably conserves the 
portion of the spinal cord that contains the SNB. The spinal cord was then extracted by 
inserting a dowel into the caudal end of the trimmed portion of the spinal column and 
pushing. 
 Animals were then placed back in the supine position, and an incision was made 
in the midline of the scrotum. Blunt dissection was performed to expose the perineal 
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muscles. The BC/LA muscle complex was then removed and dissected into its 
component muscles, which were weighed separately. 
 Extracted spinal cords were then postfixed in cold 1% paraformaldehyde/1.25% 
glutaraldehyde for 5 hours, and stored in cold sucrose phosphate buffer (10% w/v, pH 
7.4) overnight for cryoprotection. Spinal roots were then removed, leaving only a small 
stump for each, and spinal cords were trimmed to include only the 5th and 6th lumbar 
segments and the 1st sacral segment, the portion of the cord that contains the SNB. Spinal 
cords were then embedded in a gelatin block, which was subsequently fixed and 
cryoprotected overnight in a cold solution of 10% sucrose phosphate buffer and fixative. 
The embedded spinal cords were then frozen-sectioned transversely at 40 µm. Sections 
were collected into four alternating series, so that the distance between the centers of 
consecutive sections in each series was 160 µm. 
 One series was immediately mounted onto slides coated with porcine gelatin and 
allowed to dry for three days. They were then stained with thionin and coverslipped with 
Permount. This series was used for cell counting (see below). The other three series were 
processed for HRP visualization using tetramethyl benzidine as a chromagen, which 
makes the HRP label appear black (or exceedingly dark blue). These series were then 
mounted onto porcine gel-coated slides, allowed to dry for three days, counterstained 
with thionin, and coverslipped with Permount. These three series were used for 
motoneuron morphometry (see below). 
 Cell counting 
 SNB motoneurons are large, multipolar neurons. They stain darkly with thionin, 
reside in a discrete area in the spinal cord, and are easily recognizable (see Figure 2.1).  
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FIGURE 2.1 
Photomicrograph of SNB motoneurons 6 days after unilateral injection of saporin into the 
right BC and LA muscles; depletion of motoneurons in the right half of the nucleus is 
apparent, as is concomitant gliosis. 
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Because HRP labeling can obscure thionin stained motoneurons, and thus result in 
spuriously low cell counts, motoneurons were counted only in the series that was not 
processed for HRP visualization. To correct for the fact that motoneurons were counted 
in only every fourth section, motoneuron counts were multiplied by four to determine a 
total for each animal. Counting every motoneuron that has a piece contained in the 
section being examined would lead to an artificially inflated cell count, because 
motoneurons that extend into consecutive sections would contribute to cell counts more 
than once. To correct for this, motoneuron profiles that extended through the top of the 
section were not counted; I only counted motoneurons that were wholly contained within 
the section or that extended through the bottom of the section. Motoneurons were counted 
separately on both sides of the spinal cord, under brightfield illumination and at a final 
magnification of 500X.  
 Motoneuron morphometry 
 Measurements of motoneuron morphology were taken in the three series 
processed for HRP visualization. HRP-labeled SNB motoneurons were counted in every 
section of each of these series in exactly the same way that thionin-stained motoneurons 
were counted in the other series. 
 Soma size. Cross-sectional motoneuron area was determined by using a video-
based computerized morphometry system (Stereo Investigator; MicroBrightField, 
Colchester, VT) to trace the profiles of HRP-filled SNB somata, under brightfield 
illumination and at a final magnification of 780X. A minimum of approximately 20 
motoneurons per animal were traced, encompassing at least one entire series. Sometimes 
it was necessary to trace SNB motoneuron profiles from more than one series in order to 
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collect the minimum number. In these cases, somata were traced for the entire 
rostrocaudal extent of each series used. This was done to avoid any possible size bias that 
might have been introduced by tracing motoneurons preferentially from one end of the 
nucleus.2 Soma areas within each animal were then averaged for statistical analysis. In 
addition, individual soma areas were sorted into 100-µm2 bins, and group differences in 
their frequency distributions were assessed by χ2 analyses.3
 Dendrites. For each animal, measures of dendritic length, distribution, and extent 
were all taken from a single series processed for HRP visualization. This series was 
determined by picking the series that had the middle number of HRP-labeled SNB 
motoneurons (i.e., neither the series with the greatest number nor the series with the least 
number was used). In cases in which two series had the same number of HRP-labeled 
motoneurons, a qualitative evaluation of the amount of dendritic arbor was made, and the 
series that would yield the most conservative result was used, thus minimizing the 
chances of producing a spurious effect. 
 Length. Using the predetermined series, and beginning with the most rostral 
section in which HRP-labeled processes were visible, I used a computer-based 
morphometry system (Neurolucida; MicroBrightField) connected to a camera lucida to 
trace the dendritic arbor in three dimensions. Tracings were made under darkfield 
illumination at a final magnification of 250X, and were collected from every other 
section in the series (centers were 320 µm apart) through the entire rostrocaudal extent of 
the nucleus. The lengths of all the traced processes were then summed, multiplied by two 
                                                     
2 SNB motoneurons near the rostral end of the nucleus tend to have larger somata than those near the 
caudal end. Moreover, SNB motoneurons from the rostral vs. caudal ends of the nucleus have been shown 
to have differential sensitivity to some experimental manipulations. 
3 In some cases, extreme low and high bins were grouped in order to avoid expected values of less than 
one, which would invalidate conclusions drawn from the χ2 test. 
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to correct for sampling, and divided by the number of HRP-labeled motoneurons in the 
traced series. This method assesses dendritic length throughout the dendritic arbor of the 
entire nucleus, and yields an estimate of dendritic length per motoneuron. While this 
estimate does not represent a measurement of actual total dendritic length for the nucleus 
(Kurz et al., 1991), it has proven to be a sensitive and reliable indicator of changes in 
dendritic morphology during normal development (Goldstein et al., 1993; Goldstein et 
al., 1990; Goldstein and Sengelaub, 1993), in response to hormonal manipulations (Burke 
et al., 1999; Burke et al., 1997; Forger and Breedlove, 1987; Goldstein et al., 1990; 
Goldstein and Sengelaub, 1993; Goldstein and Sengelaub, 1994; Hebbeler and 
Sengelaub, 2003; Hebbeler et al., 2001; Hebbeler et al., 2002; Kurz et al., 1991; Kurz et 
al., 1986), after changes in dendritic interactions (Goldstein et al., 1993) and afferent 
input (Hebbeler and Sengelaub, 2003; Hebbeler et al., 2002; Kalb, 1994), and after 
induced motoneuron death (Fargo and Sengelaub, 2004a, 2004b). In keeping with the 
established literature, for the sake of simplicity, this measure is referred to throughout 
this thesis as either “dendritic length” or “arbor per cell”. 
 Distribution. A set of radial axes was then applied to the transverse aspect of the 
computerized tracings. These axes originated at the central canal and divided the spinal 
cord into 12 radial bins of 30° each. Dendritic length per motoneuron was then 
determined for each radial bin by summing the lengths within that bin, multiplying by 
two to correct for sampling, and dividing the result by the number of HRP-labeled 
motoneurons in the traced series. This measure, then, is essentially the same as the 
dendritic length measure, but apportioned into radial bins. This method provides a 
sensitive measure of dendritic redistribution in response to changes in dendritic 
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interactions (Goldstein et al., 1993) and afferent input (Hebbeler and Sengelaub, 2003; 
Hebbeler et al., 2002), and after induced motoneuron death (Fargo and Sengelaub, 2004a, 
2004b). In keeping with the previous literature, this measure is referred to throughout this 
thesis as “dendritic length per bin” or “arbor per cell per bin”. 
 Extent. Using the same set of axes, I then measured in each radial bin the simple 
linear distance between the central canal and the most distal HRP-labeled process. This 
provides an estimate of the maximal extent of the dendritic field in the mediolateral 
plane, as well as providing another measure of dendritic distribution. The extent of the 
dendritic arbor was also measured rostrocaudally. I counted the number of sections that 
contained HRP label in the series used for morphometry. As the centers of these sections 
are 160 µm apart, I multiplied this count by 160 µm to arrive at an estimate of the linear 
distance between the most rostral and most caudal HRP-labeled processes. For the sake 
of simplicity, these measures are referred to throughout this thesis simply as “radial 
dendritic extent” and “rostrocaudal dendritic extent”. 
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Chapter 3. 
 
Does Testosterone Protect against Motoneuron Atrophy 
Induced by Depletion of Ipsilateral Motoneurons? 
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 The SNB is a medial motor nucleus, and extends dendrites throughout a large area 
of the surrounding neuropil, including prominent projections across the midline where 
their dendritic arbors overlap with those of their contralateral counterparts (Collins et al., 
1991; Goldstein et al., 1993; Kurz et al., 1986; Rose and Collins, 1985; Sasaki and 
Arnold, 1991). This is the normal pattern for medial motor nuclei. However, the majority 
of spinal motoneurons lie in the lateral motor columns, and their dendrites do not overlap 
with their contralateral counterparts. Instead, they overlap with other motoneuron 
populations that also reside in the lateral motor columns but project to different 
(ipsilateral) muscles. Overlapping dendritic fields provide several possible ways in which 
motoneuron populations can influence each other: they offer a discrete area for common 
afferents to project to, they allow for dendro-dendritic chemical signaling, they are likely 
nourished and modulated by a common population of glia (in some cases even by the 
same individual glial cells), and specifically in the case of the SNB, they allow for 
electrical signaling between sub-populations via gap junctions (Coleman and Sengelaub, 
2002). 
 Overlapping dendritic fields, then, represent a promising potential object of study 
in examining the neuroprotective effects of testosterone following motoneuron depletion. 
Based only on the observations made in the previous studies (Fargo and Sengelaub, 
2004a, 2004b), one cannot rule out the possibility that the atrophy induced by 
motoneuron depletion is limited to medial motoneurons that innervate the same muscle 
on the other side of the body and have contralaterally overlapping dendritic arbors. While 
this would still be interesting from a basic neuroscience perspective, the beneficial effects 
of testosterone treatment would be more broadly applicable if they extend to motoneuron 
 28
populations that reside on the same side of the spinal cord and have ipsilaterally 
overlapping dendritic arbors. Thus, this experiment is designed to unilaterally deplete a 
population of motoneurons, and examine the effects of testosterone treatment on 
remaining ipsilateral motoneurons that share its dendritic field. 
 Because the majority of motoneurons lie in the lateral motor columns, the ideal 
endpoint is to test these effects in lateral motor column populations. However, given that 
we know that the SNB responds to contralateral motoneuron depletion with atrophy and 
is particularly sensitive to testosterone, a logical first step is to attempt an ipsilateral 
experiment in the SNB. Therefore, I have addressed the question by unilaterally depleting 
SNB motoneurons, then examining the morphology of surviving SNB motoneurons that 
reside on the same side of the spinal cord but project to a different muscle. The SNB 
contains three distinct populations of motoneurons that can be defined by the muscles 
they innervate: those that project to the BC, those that project to the LA, and those that 
project to the external anal sphincter (EAS; McKenna and Nadelhaft, 1986; Schrøder, 
1980). If the atrophy observed in the previous studies is related to overlapping dendritic 
arbors, then I ought to be able to be able to kill motoneurons in one of the SNB 
populations and observe atrophy in motoneurons of another SNB population on the same 
side of the spinal cord. More importantly, if the overlapping dendritic arbors provide 
testosterone with a substrate on which to exert its beneficial effects, testosterone 
treatment should prevent this atrophy. 
METHODS AND DESIGN 
 The majority of SNB motoneurons project to the BC, with most of the remainder 
projecting to the LA, and a few projecting to the EAS (Kurz et al., 1990; McKenna and 
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Nadelhaft, 1986; Schrøder, 1980). In my previous experiments, I have ensured the death 
of a large majority of SNB motoneurons by injecting saporin into both the BC and LA. 
However, killing both BC- and LA-projecting SNB motoneurons leaves only the EAS-
projecting motoneurons to visualize on the ipsilateral side of the body. I decided against 
attempting to visualize EAS-projecting motoneurons for three reasons. First, it is 
technically difficult to make HRP injections reliably into the EAS. Second, the small 
number of neurons that project to the EAS would reduce the stability of my 
morphological measures, thus decreasing the sensitivity of the experiment and 
necessitating the use of more animals for no theoretical gain over using the other 
motoneuron populations. Third and most importantly, the morphology of EAS-projecting 
motoneurons is not affected by testosterone manipulation (Collins et al., 1992). In fact, I 
am unaware of any previous studies that have used morphological measures of dendrites 
of HRP-labeled EAS-projecting motoneurons as dependent variables. 
 This left the option of killing only BC- or LA-projecting motoneurons, then 
examining the morphology of motoneurons in the remaining subpopulation. Both BC- 
and LA-projecting motoneurons have been used to study the effects of steroid hormone 
treatment on spinal motoneurons (e.g, Kurz et al., 1990; Kurz et al., 1986). LA-projecting 
motoneurons were chosen for morphometry because there are more BC-projecting 
motoneurons (Kurz et al., 1990), thus offering the opportunity to kill a large portion of 
SNB motoneurons (those that project to the BC) while still leaving enough alive (those 
that project to the LA) to collect reliable measures. 
 Adult male Sprague Dawley rats were used. Saporin injections were made into 
only the BC muscle on the left side of the animal. Saporin injections were made 
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according to the method described in Chapter 2, with the exception that a 1 µl injection 
was made into the BC only, and no saporin injection was made into the LA. Coincident 
with saporin injection, some animals were also simultaneously castrated and given 
replacement testosterone according the methods described in Chapter 2 (saporin only n = 
7, saporin and testosterone treatment n = 6). A group of untreated intact normal males (n 
= 6) and a group of untreated castrates (n = 4) served as control groups. Four weeks after 
saporin injection and testosterone-treatment onset, I injected HRP into only the LA 
muscle on the left side (ipsilateral to the motoneuron depletion). The HRP injection was 
carried out according to the method described in Chapter 2, with the exception that the 
injection was made into the ipsilateral LA instead of the contralateral BC. After two 
additional days to allow for optimal HRP transport, animals were killed and the left side 
perineal musculature removed and weighed. Lumbosacral spinal cords were removed and 
processed for motoneuron counts and morphometry according to the methods described 
in Chapter 2. 
RESULTS 
Muscle Weights 
 Intramuscular injection of saporin into the BC muscle significantly reduced BC 
muscle weight [0.379 ± 0.025 g (mean ± SEM) for saporin-injected animals compared to 
0.492 ± 0.020 g for normal controls, LSD, p < .001; overall test for the effect of group on 
BC muscle weight F(3, 19) = 26.16, p < .001; see Figure 3.1, left]. Treatment with 
testosterone completely prevented this muscular atrophy (0.494 ± 0.018 g for saporin-
injected animals treated with testosterone; compared to normal controls, LSD, ns). 
Consistent with the previous literature (Fargo and Sengelaub, 2004a; Wainman and  
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Shipounoff, 1941), castration significantly reduced BC muscle weight (0.240 ± 0.015 g 
for castrated controls; compared to normal controls, LSD, p < .001). 
 LA muscle weight displayed a much different pattern. Consistent with the 
previous literature (Eisenberg et al., 1949; Fargo and Sengelaub, 2004a; Wainman and 
Shipounoff, 1941), castration significantly reduced LA muscle weight (0.078 ± 0.007 g 
for castrated controls compared to 0.170 ± 0.015 g for normal controls, LSD, p < .001; 
overall test for the effect of group on LA muscle weight F(3, 19) = 15.21, p < .001; see 
Figure 3.1, right]. However, neither saporin injection into the BC nor testosterone 
treatment had a significant effect on LA muscle weight (0.174 ± 0.008 g for saporin-
injected animals and 0.195 ± 0.013 g for saporin-injected animals treated with 
testosterone; compared to normal controls, LSDs, ns). 
Cell Counts 
 Because lateral differences are irrelevant in this experiment, motoneuron counts 
were made only on the side of the animal that was injected with saporin. Injection of 
saporin into the BC muscle resulted in the death of over 40% of ipsilateral SNB 
motoneurons [61.71 ± 10.14 remaining motoneurons for saporin-injected animals 
compared to 108.00 ± 7.01 for normal controls, LSD, p < .01; overall test for the effect of 
group on motoneuron number F(3, 19) = 6.46, p < .01; see Figure 3.2], and treatment 
with testosterone did not prevent this (56.17 ± 10.30 remaining motoneurons for saporin-
injected animals treated with testosterone; compared to normal controls, LSD, p < .01). 
Consistent with previous studies (Breedlove and Arnold, 1981; Fargo and Sengelaub, 
2004a, 2004b), castration did not result in the death of SNB motoneurons (98.00 ± 6.77 
remaining motoneurons for castrated controls; compared to normal controls, LSD, ns);  
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FIGURE 3.2 
Number of surviving SNB motoneurons for normal controls, untreated saporin-injected 
animals, saporin-injected animals treated with testosterone, and castrated controls. 
Saporin injection into the BC muscle resulted in the death of approximately 40% of SNB 
motoneurons. Treatment with testosterone did not prevent this. Cell counts are unilateral, 
and were taken on the left side of the animal in every case. * indicates significantly 
different from normal controls, p < .01. Bar heights represent means ± SEM. 
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the numbers of SNB motoneurons in both castrated and normal controls were well within 
the normal range. 
Morphometry 
 Somata 
 Somata were traced for an average of 20.13 ± 0.89 HRP-labeled motoneurons per 
animal, and this did not differ between groups [F(3, 19) = 0.47, ns]. Soma area was an 
average of 950.69 ± 37.27 µm2, and group differences did not reach significance [F(3, 
19) = 2.07, ns]. However, soma areas for castrated controls (763.88 ± 73.93 µm2) were 
much smaller than for any other group, whereas saporin-injected animals, both untreated 
(991.61 ± 56.65 µm2) and testosterone-treated (970.47 ± 53.31 µm2), had soma areas very 
similar to those of normal controls (1007.33 ± 90.18 µm2; see Figure 3.3). 
 χ2 analysis of individual soma areas yielded similar results (see Figure 3.4). 
Neither saporin-injected animals nor saporin-injected animals treated with testosterone 
had frequency distributions that were different from that of normal controls [χ2s(13) ≤ 
13.18, ns]. In contrast, castration alone shifted the distribution of individual soma areas 
significantly toward the lower end of the spectrum [compared to normal controls, χ2(13)  
= 37.09, p < .001; overall test for the effect of group on the distribution of individual 
soma areas χ2(39) = 79.34, p < .001]. 
 Dendrites
 Injection of HRP into the left LA successfully labeled ipsilateral SNB 
motoneurons in a manner consistent with previous studies (Kurz et al., 1991). SNB 
motoneurons displayed their characteristic multipolar morphologies (Kurz et al., 1991; 
Kurz et al., 1986; Sasaki and Arnold, 1991), with dendritic arbors projecting  
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FIGURE 3.3 
Cross-sectional soma areas of LA-projecting SNB motoneurons for normal controls, 
untreated saporin-injected animals, saporin-injected animals treated with testosterone, 
and castrated controls. No group differed significantly from normal (however, see the text 
regarding castrated controls). Bar heights represent means ± SEM. 
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FIGURE 3.4 
Frequency distributions of individual soma areas of LA-projecting SNB motoneurons for 
normal controls, untreated saporin-injected animals, saporin-injected animals treated with 
testosterone, and castrated controls. Only castrated controls had a frequency distribution 
different from that of normal controls, with castration shifting the distribution toward 
smaller somata. * indicates significantly different from normal controls, p < .001. 
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ventrolaterally, dorsomedially, and across the midline into the area of the contralateral 
SNB (Figure 3.5). An average of 35.13 ± 2.41 motoneurons were labeled with HRP, and 
this did not differ between groups [F(3, 19) = 1.59, ns]. This is markedly fewer than the 
number of labeled motoneurons typically found when HRP is injected into the BC muscle 
(average of about 57 motoneurons; Fargo and Sengelaub, 2004a, 2004b), and reflects the 
fact that there are fewer LA-projecting than BC-projecting motoneurons in the SNB 
(Kurz et al., 1990). 
 Saporin treatment reduced dendritic length by almost 60% [3836.72 ± 1114.31 
µm for saporin-injected animals compared to 9089.44 ± 2065.54 µm for normal controls; 
LSD, p < .05; overall test for the effect of group on dendritic length F(3, 19) = 3.40, p < 
.05; see Figure 3.6]. Surprisingly, treatment of saporin-injected animals with testosterone 
completely failed to prevent this dendritic atrophy (4364.33 ± 1034.88 µm; compared to 
normal controls, LSD, p < .05). Castrated controls also displayed significant dendritic 
atrophy (3746.82 ± 582.94 µm; compared to normal controls, LSD, p < .05). 
 Dendritic length was nonuniform across radial bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 209) = 77.70, p < .001]. 
Consistent with the results of the arbor per cell analysis, there was also a significant 
effect of group [F(3, 19) = 3.42, p < .05]. Saporin injection led to reductions in arbor 
length of approximately 81% from 0° to 30°, 75% from 30° to 60°, 72% from 60° to 90°, 
74% from 90° to 120°, 64% from 120° to 150°, 60% from 150° to 180°, 61% from 180° 
to 210°, 44% from 210° to 240°, 50% from 240° to 270°, 56% from 270° to 300°, 52% 
from 300° to 330°, and 70% from 330° to 360° (see Figure 3.7). 
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FIGURE 3.5 
Left: Darkfield photomicrographs of transverse sections through the lumbar spinal cords 
of a normal control, an untreated saporin-injected animal, and a saporin-injected animal 
treated with testosterone, after HRP injection into the left LA muscle. Right: Computer-
generated composites of HRP-labeled somata and processes drawn at 320 µm intervals 
through the entire rostrocaudal extent of the SNB; these composites were selected 
because they are representative of their respective group average dendritic lengths. 
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FIGURE 3.6 
Dendritic lengths of LA-projecting SNB motoneurons for normal controls, untreated 
saporin-injected animals, saporin-injected animals treated with testosterone, and castrated 
controls. Saporin injection into the BC muscle reduced the dendritic length of ipsilateral 
LA-projecting motoneurons by almost 60%. Treatment with testosterone completely 
failed to prevent this atrophy. * indicates significantly different from normal controls, p < 
.05. Bar heights represent means ± SEM. 
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FIGURE 3.7 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB 
dendritic distribution. Bottom: Length per radial bin of SNB dendrites in normal controls, 
untreated saporin-injected animals, saporin-injected animals treated with testosterone, 
and castrated controls. For graphic purposes, dendritic length measures have been 
collapsed into 6 bins of 60° each. Saporin injection reduced dendritic length in every bin, 
and testosterone treatment did not prevent this. * indicates significantly different from 
normal controls, p < .05. Bar heights represent means ± SEM. 
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 Radial dendritic extent was nonuniform across bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 209) = 67.96, p < .001]. 
However, radial dendritic extent was not affected by saporin injection, testosterone 
treatment, or castration: it did not differ between groups [F(3, 19) = 2.40, ns], and there 
was no interaction between radial location and group [F(33, 209) = 1.02, ns; see Figure 
3.8]. Additionally, rostrocaudal dendritic extent for normal controls (3226.67 ± 275.33 
µm), saporin-injected animals (2742.86 ± 176.06 µm), saporin-injected animals treated 
with testosterone (2666.67 ± 173.64 µm), and castrated controls (3040.00 ± 146.06 µm) 
did not differ each other [F(3, 19) = 1.63, ns; grand mean 2900.87 ± 108.48 µm]. 
DISCUSSION 
Muscle Weights 
 Saporin injection into the BC muscle decreased BC muscle weight (Figure 3.1, 
left). This is completely consistent with the previous experiments (Fargo and Sengelaub, 
2004a, 2004b) and with the experiments described in Chapters 4 and 6 of this thesis, in 
which injection of saporin into both the BC and LA resulted in dramatic weight loss in 
the injected musculature. 
 Testosterone treatment completely prevented the saporin-induced atrophy of the 
BC muscle (Figure 3.1, left). This serves as an important manipulation check in this 
experiment, given that testosterone treatment failed to prevent atrophy of the LA- 
projecting motoneurons. Testosterone treatment does not always prevent the muscular 
atrophy induced by saporin injection. In one previous experiment (Fargo and Sengelaub, 
2004a) testosterone treatment prevented atrophy of the saporin-injected muscles, while in 
another (Fargo and Sengelaub, 2004b) it did not. In the experiment described in Chapter  
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FIGURE 3.8 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB radial 
dendritic extent. Bottom: Radial extents of SNB dendrites in normal controls, untreated 
saporin-injected animals, saporin-injected animals treated with testosterone, and castrated 
controls. For graphic purposes, dendritic extent measures have been collapsed into 6 bins 
of 60° each. SNB radial dendritic extent is non-uniform across radial bins. However, 
radial dendritic extent did not differ between groups, nor was there any interaction 
between group and radial bin. Bar heights represent means ± SEM. 
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6 of this thesis testosterone treatment attenuated, but did not completely prevent, atrophy 
of the saporin-injected musculature. 
 In the current experiment, the motoneurons labeled with HRP and visualized for 
morphometry were LA-projecting SNB motoneurons ipsilateral to the saporin injection. 
The weight of the ipsilateral LA was not significantly affected by either saporin injection 
or treatment with exogenous testosterone (Figure 3.1, right). The fact that LA weight was 
not affected by testosterone treatment was unexpected. In previous experiments (Fargo 
and Sengelaub, 2004a, 2004b) and in the experiment described in Chapter 6, testosterone 
treatment has led to the hypertrophy of the perineal musculature not injected with 
saporin. Indeed, testosterone is a powerful anabolic steroid, and the weight of the perineal 
musculature is particularly responsive to its manipulation (Eisenberg et al., 1949; 
Wainman and Shipounoff, 1941).1 Perhaps the saporin injected into the nearby BC 
muscle leaked in the periphery and spread to the LA. If saporin did indeed leak and 
spread to the LA, there was not enough of it to cause LA atrophy, but there may have 
been enough to attenuate testosterone’s ability to cause muscular hypertrophy in the LA. 
 The fact that the LA did not suffer atrophy in the untreated saporin-injected 
animals is an important observation. I argue that the dendritic atrophy observed in LA-
projecting motoneurons following saporin injection into the BC was secondary to the 
death of BC-projecting motoneurons. As mentioned above, though, it is possible that 
                                                     
1 It is interesting to note that testosterone was ineffective both in causing LA hypertrophy and in rescuing 
LA-projecting motoneurons from dendritic atrophy following saporin injection into the BC. It is even 
possible that the two results are causally linked. It is known that denervation abolishes the ability of 
testosterone treatment to increase LA muscle weight and protein synthesis (Burešová et al., 1972; Rand and 
Breedlove, 1992). Perhaps the atrophy observed in LA-projecting motoneurons is so profound that they are 
rendered incapable of activating the LA. Such a functional denervation of the LA could be expected to 
abolish the ability of testosterone to cause muscular hypertrophy. Of course, this might also be expected to 
lead to the kind of atrophy observed after mechanical denervation of the perineal musculature (Burešová et 
al., 1972; Chapter 5 of this thesis), which it did not do. 
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saporin leaked from the BC and spread to the LA in the periphery, where it could then 
have acted directly on LA-projecting motoneurons. This alternative explanation for the 
effect of saporin injection on the dendritic morphology of LA-projecting motoneurons 
cannot be ruled out by the current data. However, the fact that the LA’s weight was 
unchanged in untreated saporin-injected animals increases my confidence that saporin did 
not act directly at the LA. This observation is in concert with previous experiments 
(Fargo and Sengelaub, 2004a, 2004b) and with the experiment described in Chapter 6 of 
this thesis, in which saporin injection into one side of the BC/LA did not alter muscle 
weights on the uninjected side. 
Cell Counts 
 Injection of saporin into the BC muscle resulted in the death of over 40% of the 
motoneurons in the ipsilateral SNB (Figure 3.2). Although it is not possible to determine 
whether this cell death was specific to BC-projecting motoneurons, there are at least three 
reasons to make this assumption. First, in previous experiments (Fargo and Sengelaub, 
2004a, 2004b) and in the experiment described in Chapter 6, saporin injection into one 
side of the BC/LA musculature did not result in any motoneuron death on the other side 
of the animal, and the BC and LA muscles on either side of the body are just as proximal 
to each other as are the BC and LA muscle on one side. Second, the number of 
motoneurons labeled with HRP in this experiment did not differ between groups. Recall 
that the HRP-labeled motoneurons in this experiment project to the LA; if LA-projecting 
motoneurons were killed by injection of saporin into the BC muscle, then I would expect 
fewer of them to be labeled in the saporin-injected groups. Third, injection of saporin into 
the BC only resulted in the death of around 40% of ipsilateral SNB motoneurons, while 
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injection of saporin into both the BC and the LA results in the death of more than 60% of 
ipsilateral SNB motoneurons (Fargo and Sengelaub, 2004a, 2004b; Chapter 6); 
presumably, the additional 20% or so are LA-projecting motoneurons. For these reasons, 
I am making the assumption that saporin injection into the BC in this experiment resulted 
in the death of only BC-projecting motoneurons. 
 In some experimental paradigms, treatment with exogenous steroids prevents 
injury-induced motoneuron death ( e.g., Ahlbom et al., 2001; Hammond et al., 2001; 
Huppenbauer et al., 2005; Pike, 2001; Ramsden et al., 2003). It is therefore important to 
note that saporin injection resulted in motoneuron death regardless of testosterone 
treatment in the present experiment. Because of this, any potential beneficial effect of 
testosterone treatment on the morphology of the remaining, LA-projecting motoneurons 
cannot be attributed to testosterone attenuating the motoneuron depletion induced by 
saporin injection. 
Morphometry 
 The number of motoneurons labeled with HRP did not differ between groups. 
Therefore, it is unlikely that differences in measures of motoneuron morphology between 
groups were affected by potential differences in the number of motoneurons labeled with 
HRP. 
Somata 
 Group differences in mean cross-sectional soma area did not reach significance 
(Figure 3.3). Despite this, castrated controls had smaller somata than any other group, 
and castration has long been known to reliably shrink SNB somata (Araki et al., 1991; 
Breedlove and Arnold, 1981; Collins et al., 1992; Fargo and Sengelaub, 2004a; Forger et 
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al., 1992). The most important point to make here, though, is that saporin injection into 
the BC muscle did not result in somal atrophy in ipsilateral LA-projecting motoneurons. 
This result stands in contrast with earlier studies (Fargo and Sengelaub, 2004a, 2004b) 
and the experiment described in Chapter 6, in which saporin injection into BC and LA 
resulted in the somal atrophy of contralateral BC-projecting motoneurons. While this 
might be attributed to a simple lack of sensitivity in the current study, it should be noted 
that the technique I used to measure soma area in this study is no different from what I 
used in the other studies. One might still argue that this technique is less sensitive for LA-
projecting motoneurons than for BC-projecting motoneurons, but the large difference 
between castrates and the other groups makes this explanation unlikely. Given the lack of 
a plausible alternate explanation, I must conclude that there really was no effect of 
saporin injection into the BC muscle on soma areas of ipsilateral LA-projecting 
motoneurons. 
 It is difficult to interpret this difference between studies because the measured 
cells in the current study differ from the others in at least three important ways—first, 
they are LA-projecting rather than BC-projecting motoneurons; second, they are 
ipsilateral rather than contralateral to the saporin injection; and third, only one rather than 
two of their neighboring subpopulations has been depleted by saporin injection. The lack 
of an effect of saporin injection might be attributable to any of these differences. 
 Potential group differences in soma areas were also assessed by creating 
frequency distributions of the individual soma areas in each group. The results of this 
analysis were similar to those obtained by examining mean soma areas. Neither saporin 
injected animals nor saporin-injected animals treated with testosterone had frequency 
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distributions that differed from that of normal controls. Only castration alone changed the 
distribution of individual soma areas. Castrated controls had more small somata and 
fewer medium and large somata. 
Dendrites 
 Injection of saporin into the BC muscle resulted in significant dendritic atrophy of 
ipsilateral LA-projecting motoneurons (Figure 3.6). This result is in line with previous 
experiments (Fargo and Sengelaub, 2004a, 2004b), and along with the results of the 
experiment described in Chapter 6, provides important confirmatory evidence that 
motoneuron depletion by intramuscular saporin injection leads to atrophy of surviving 
motoneurons in nearby pools. Indeed, even the amount of dendritic retraction 
(approximately 60%) was very similar to what is seen in other studies. 
 Surprisingly, however, treatment with exogenous testosterone had absolutely no 
beneficial effect on dendritic length. As with soma area, this result stands in stark contrast 
with previous studies (Fargo and Sengelaub, 2004a, 2004b) and the results of the 
experiment described in Chapter 6. Unfortunately, it is equally as difficult to interpret, 
primarily because the mechanism of action for testosterone in this model is unknown. For 
example, if testosterone exerts its protective effects on BC-projecting motoneurons by 
acting directly on the neurons, then one might speculate that the lack of a protective 
effect of testosterone treatment in the current experiment is due to some intrinsic 
characteristic of LA-projecting motoneurons that makes them less sensitive to 
testosterone than BC-projecting motoneurons. 
 Alternatively, if the site of action for testosterone is at the muscle, one might 
speculate that the LA is not capable of responding to testosterone treatment as vigorously 
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as does the BC. In this case, it might be that some trophic factor that protects 
motoneurons is upregulated by the BC, but not the LA, in response to testosterone 
treatment. In fact, this is an attractive hypothesis. In the present experiment testosterone 
treatment had no effect on LA muscle weight (Figure 3.1), but in previous studies (Fargo 
and Sengelaub, 2004a, 2004b) and in the experiment described in Chapter 6, in which 
testosterone treatment was protective of dendritic length, the measured motoneurons 
projected to muscles that were significantly hypertrophied in the testosterone-treated 
animals. So there is at least a correlation between muscle hypertrophy and dendritic 
protection in testosterone-treated animals.2 Moreover, it is known that testosterone 
depends on the presence of BDNF, probably supplied by the muscle in vivo, to support 
normal dendritic length in the SNB (Yang et al., 2004). 
 Of course, other possible explanations exist for the lack of a protective effect of 
testosterone on LA-projecting motoneurons in this experiment. For example, connectivity 
between the affected subpopulations of motoneurons might be different between this 
experiment and previous experiments. BC-projecting motoneurons are connected to 
contralateral SNB motoneurons by gap junctions (Coleman and Sengelaub, 2002), and 
BC-projecting motoneurons are protected from dendritic atrophy when the contralateral 
SNB motoneurons are killed by intramuscular saporin injection (Fargo and Sengelaub, 
2004a, 2004b; Chapter 6). In contrast, it has never been shown that LA-projecting 
motoneurons are connected by gap junctions to other ipsilateral SNB motoneurons—and 
LA-projected motoneurons are not protected when ipsilateral BC-projecting motoneurons 
are killed. It is therefore at least reasonable to wonder if testosterone’s inability to protect 
                                                     
2 However, the results reported in Chapter 6, with special attention paid to the dihydrotestosterone-treated 
group, suggest that muscle hypertrophy is not a necessary precondition for androgenic protection of SNB 
dendritic length. 
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LA-projecting motoneurons in this experiment is related to a potential lack of 
connectivity between those motoneurons and the BC-projecting motoneurons that were 
killed. A similar hypothesis arises from the fact that LA-projecting motoneurons are 
spatially intermingled with ipsilateral BC-projecting motoneurons while the somata in the 
contralateral motoneuron pools are completely separated (McKenna and Nadelhaft, 
1986). Perhaps testosterone is incapable of rescuing motoneuron dendrites from atrophy 
when the somata of the measured neurons are closely intermingled with those that are 
killed.3
 The possibility that saporin injection could depress retrograde transport of HRP 
and produce spuriously low measures of dendritic length is an important consideration. 
However, measures of dendritic extent would also be affected by depression of retrograde 
transport, and in the current experiment neither radial dendritic extent (Figure 3.8) nor 
rostrocaudal dendritic extent differed between groups, making this unlikely. 
Conclusions 
 The purpose of the present experiment was to examine whether or not testosterone 
treatment would protect motoneurons from regressive changes following the death of 
ipsilateral motoneurons. Dendritic length was markedly reduced in saporin-injected 
animals regardless of treatment with testosterone, suggesting that testosterone treatment 
is not capable of producing such a protective effect. However, these results are made 
difficult to interpret further because the motoneurons examined in this experiment differ 
from those in previous experiments in multiple ways, including their spatial relationship 
                                                     
3 However, preliminary data from our laboratory suggest that, following saporin-induced loss of quadriceps 
motoneurons, testosterone treatment rescues intermingled surviving ipsilateral quadriceps motoneurons 
from dendritic atrophy. Note that this also argues against the possibility that the protective effect of 
testosterone is “contralateral only”. 
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to the depleted motoneurons, their target musculature (including its lack of hypertrophy 
in response to testosterone treatment), and the fact that their somata did not shrink 
following saporin injection. 
 Also, based solely on the data from this experiment, one cannot rule out the 
possibility that saporin simply leaked from the BC and spread to the LA in the periphery, 
where it acted directly on the LA muscle and LA-projecting motoneurons. This would 
explain the lack of a testosterone effect in both LA muscle weight and LA-projecting 
motoneuron dendritic morphology. Recently, our laboratory has begun injecting saporin 
into the thigh muscle, vastus medialis, then examining the morphology of the ipsilateral 
vastus lateralis, another thigh muscle. This experimental setup is similar to the present 
experiment in that the depleted motoneurons and the motoneurons assessed for 
morphometry are intermingled within the same motor pool, and different from the present 
experiment in that the two muscles are located far enough away from each other as to 
make peripheral spread of saporin to the uninjected muscle highly unlikely. Preliminary 
unpublished observations indicate that testosterone treatment is effective in preventing 
saporin-induced motoneuron atrophy in that experimental design, further supporting the 
idea that the lack of a testosterone effect in the present experiment was due to leakage 
and peripheral spread of saporin. Future experiments must address this issue. The 
simplest way to rule out the leakage explanation would be to institute experimental 
controls that would prevent leakage of saporin from the BC muscle, for instance by 
closing the needle hole in the muscle with a drop of cyanoacrylate. Alternatively, protein 
expression could be examined in the BC, LA, and control muscles to rule out a direct 
effect of saporin on the LA in the periphery. 
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Chapter 4. 
 
Does Testosterone Protect against Deficits in Motor Activation Caused by Depletion of 
Contralateral Motoneurons? 
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 Motoneuron loss is a prominent feature of several movement disorders as well as 
a consequence of traumatic injuries of the spinal cord. However, motor systems have a 
high degree of redundancy, and display remarkable plasticity in the face of various 
insults. It has been suggested that this redundancy and plasticity may serve as a substrate 
for treatment strategies in disease or after spinal cord lesions (Edgerton et al., 2004). 
Given that we are, as yet, incapable of replacing lost motoneurons, the best hope for 
retaining normal function following motoneuron loss may lie in promoting the health of 
surviving motoneurons. My previous experiments (Fargo and Sengelaub, 2004a, 2004b) 
demonstrated a profound effect of testosterone in rescuing motoneurons from somal and 
dendritic atrophy following the death of their contralateral counterparts. However, while 
the effects of testosterone treatment on the morphology of the surviving motoneurons are 
striking, it is unknown whether they confer any functional benefit to the animal. The 
purpose of the present experiment, therefore, was to examine the electrophysiological 
response properties of SNB motoneurons following saporin injection, and to determine 
whether treatment with exogenous testosterone would prevent any possible 
electrophysiological deficits caused by saporin injection. 
 In males, the motoneurons of the SNB innervate the perineal BC and LA muscles, 
as well as the external anal sphincter (Breedlove and Arnold, 1980; McKenna and 
Nadelhaft, 1986; Schrøder, 1980). These BC and LA surround the base of the penis, and 
their coordinated activity mediates penile reflexes. Specifically, they produce strong, 
rhythmic contractions resulting in a cupping or flaring of the glans penis (Hart and 
Melese-D'Hospital, 1983). Penile cupping is necessary for depositing seminal plugs in the 
vaginal canal, and for removing those deposited previously by a competing male, both 
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critically important for successful copulation (Sachs, 1982). Accordingly, during 
intromission and ejaculation, the BC muscle contracts with very high frequency and 
amplitude (Holmes et al., 1991), and the activity of the system can be thought of as 
producing an “all or nothing” response. 
 Several aspects of the spinal circuitry of the SNB system have been established. 
While many spinal reflex pathways are monosynaptic, multiple lines of evidence indicate 
that the SNB reflex pathway is polysynaptic. The pudendal nerve afferents terminate in 
the dorsal gray commissure (McKenna and Nadelhaft, 1986), the site of a large 
population of interneurons that terminate on SNB motoneurons (Collins et al., 1991). In 
addition, the relatively long delay between stimulation of the pudendal afferents and the 
onset of activity in SNB motor axons (~4.5 msec) is inconsistent with a monosynaptic 
circuit, even at the highest recorded conduction velocities of SNB afferent and efferent 
fibers (McKenna and Nadelhaft, 1989). Furthermore, stimulation of the pudendal 
afferents produces a mixture of both IPSPs and EPSPs in SNB motoneurons (Collins, 
1985). 
 Another prominent feature of the SNB spinal circuitry is its bilateral organization. 
Afferent pudendal nerve axons arborize in both the ipsilateral and contralateral dorsal 
gray commissure (McKenna and Nadelhaft, 1986). Additionally, the dendritic fields of 
the left and right sides of the SNB overlap extensively, and SNB motoneuron dendrites 
even directly appose the somata of contralateral SNB motoneurons (Kurz et al., 1986; 
Rose and Collins, 1985). Moreover, SNB motoneurons are connected to their 
contralateral counterparts via gap junctions (Coleman and Sengelaub, 2002). The bilateral 
organization of the SNB spinal circuitry gives rise to bilateral patterns of activity in the 
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penile reflexes, with stimulation of the pudendal afferents producing activity in both 
ipsilateral and contralateral SNB motor axons (Foster and Sengelaub, 2004a; McKenna 
and Nadelhaft, 1989; Tanaka and Arnold, 1993). 
 As reviewed in Chapter 1, several features of SNB spinal circuitry are dependent 
on steroid hormones. Among these, of particular importance in SNB motoneurons are the 
morphology of both somata and dendrites (Breedlove and Arnold, 1981; Kurz et al., 
1986; Sasaki and Arnold, 1991), the amount of synaptic input (Leedy et al., 1987; 
Matsumoto et al., 1988), the number and size of gap junction plaques (Matsumoto et al., 
1988), and the functional expression of N-type Ca2+ channels at the motor end plates 
(Nudler et al., 2005). Accordingly, steroid hormones are necessary to maintain normal 
electrophysiological responses in this reflex pathway. Removal of endogenous gonadal 
steroids by castration decreases the number of cups produced reflexively in response to 
retraction of the preputial sheath, and testosterone replacement reverses this (Hart, 1967). 
In addition, castration increases response latency, attenuates SNB motoneuron 
recruitment, and decreases the number of EMG spikes produced in response to afferent 
stimulation, while treatment with exogenous gonadal steroids prevents all of these 
deficits (Fargo et al., 2003; Foster and Sengelaub, 2004b; Holmes and Sachs, 1992). 
These facts suggest that the protective effects of testosterone on SNB morphology 
following saporin injection may attenuate any possible deficits in motor activation caused 
by saporin injection. 
 While the electrophysiology of injured motoneurons has been a subject of some 
study, there are only a few reports in the literature concerning the electrophysiology of 
surviving motoneurons in close proximity to an injury site. What studies there are have 
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been conducted by J.-O. Kellerth and his colleagues, working in cat. Their most recent 
studies (Havton et al., 2001; Havton and Kellerth, 2004) have utilized nerve injuries that 
do not result in motoneuron death, and shed very little light on the current dissertation 
work. However, in their original experimental setup, they killed lumbosacral 
motoneurons unilaterally by avulsion of the L7 ventral root (cats have 7 lumbar spinal 
segments, whereas rats have only 6). The lumbosacral dorsal roots were then stimulated 
bilaterally, and recordings were taken from the remaining lumbosacral ventral roots 
bilaterally. The authors reported a two-fold difference in the amplitude of reflex 
responses between the contralateral side and the ipsilateral side, with the ipsilateral side 
displaying larger responses (Holmberg and Kellerth, 1996; Holmberg and Kellerth, 
2000). The authors interpreted this as an increase in reflex strength on the ipsilateral side, 
but because only internal controls were used, it is also possible that what they saw was 
actually a decrease in strength of the reflex pathway on the side of the animal 
contralateral to the lesion. 
 The present experiment was designed to determine what electrophysiological 
changes might accompany the motoneuron atrophy induced by contralateral saporin 
injection, and moreover, to determine whether treatment with exogenous testosterone 
would prevent these changes as it prevents motoneuron atrophy. To accomplish this goal, 
I studied the electrophysiological response properties of SNB motoneurons contralateral 
to saporin injection, both with and without testosterone treatment. 
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METHODS AND DESIGN 
Animals 
 Adult male Sprague Dawley rats were used. Saporin injections were made into the 
BC and LA muscles according to the method described in Chapter 2. Coincident with 
saporin injection, some animals were also simultaneously castrated and given 
replacement testosterone according the methods described in Chapter 2 (saporin only n = 
6, saporin and testosterone treatment n = 5). A group of untreated intact normal males (n 
= 5) and a group of untreated castrates (n = 6) served as control groups. 
Peripheral Nerve Recording 
 Four weeks after saporin injection and testosterone-treatment onset, I proceeded 
with peripheral nerve recording as described by Foster and Sengelaub (2004a). Peripheral 
nerve recording is a somewhat misleading name for the procedure, as it is designed 
specifically to isolate and record from the central components of the neuromuscular 
circuit (proximal nerves, central synapses, interneurons, and motoneurons), and not the 
peripheral components (distal nerves, dorsal root ganglia, neuromuscular junctions, and 
muscles). For a schematic representation of peripheral nerve recording as used in this 
experiment, see Figure 4.1. 
 Each animal was weighed then placed under general anesthesia with an 
intraperitoneal injection of chloral hydrate (450 mg/kg body weight, with supplemental 
doses as needed to maintain areflexia to painful stimuli). Once the animal no longer 
responded to pain, it was placed in the prostrate position on a 37 °C heating pad, and an 
incision of approximately 2 cm was made through the skin, parallel to the spine and 
above the second thoracic vertebra. The skin was retracted with ophthalmic spreaders,  
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FIGURE 4.1 
Schematic representation of the procedures used in this experiment. Projections are 
drawn to illustrate the locations of nerve cuts and electrode placement, and are not 
intended to be representative of the anatomical details of the spinal circuitry. 
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and a scalpel was used to cut through the paraspinous muscles and connective tissue until 
the dorsal aspects of several thoracic vertebrae were completely exposed. The muscles 
and connective tissue were retracted with ophthalmic spreaders, and a few minutes were 
allowed to pass so that bleeding would subside before exposing the central nervous 
tissue. I then performed a dorsal laminectomy of the thoracic vertebra with the most 
prominent spinous process, and completely transected the spinal cord directly under this 
process. Spinal cord transection removes descending tonic inhibition of spinal reflexes, 
allowing for a more accurate characterization of their properties. The exposed tissue was 
covered with mineral oil to prevent desiccation, and the skin was closed with 9-mm 
AutoClips brand stainless steel wound clips. 
 Another incision was made through the skin parallel to the spine, approximately 6 
cm in length, and placed above the thirteenth thoracic and the first and second lumbar 
vertebrae. A scalpel was used to cut through the paraspinous muscles and connective 
tissue until the dorsal aspects of the vertebrae were completely exposed. The soft tissue 
was then carefully removed from between the transverse and articulating processes, 
allowing the fitting of a custom-made spinal clamp used to stabilize the spine and reduce 
potential movement artifacts during recording. After affixing the spinal clamp, I 
performed a dorsal laminectomy of the thirteenth thoracic vertebra and the first and 
second lumbar vertebrae, and carefully removed the dura from the underlying tissue. This 
exposed the caudal portion of the lumbar enlargement, in which the motoneurons of the 
SNB reside, and allowed for the visualization of the dorsal roots L5-S1. The dorsal root 
L6 contralateral to saporin injection was draped over a bipolar stimulating electrode and 
crushed to it by ligation with a short length of surgical silk suture. (The contralateral 
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dorsal root was chosen for stimulation because of the possibility that saporin injection 
resulted in damage to the ipsilateral dorsal root.) Dorsal roots L5-S1 were then severed 
(distal to the electrode) on both sides of the animal in order to reduce unwanted 
stimulation of the SNB by motor afferents. The exposed spinal region was then bathed in 
mineral oil to prevent desiccation, and additional applications of mineral oil were 
administered periodically throughout recording. 
 The tail was then elevated and immobilized, and an incision was made between 
the tail and the anus. The perineal muscles and the nerves that supply them were exposed 
by blunt dissection. The pudendal nerve motor branch carrying the efferents from the 
SNB to the BC (contralateral to saporin injection) was draped over a bipolar hook wire 
recording electrode (model PBCA0750; FHC, Bowdoinham, ME) and crushed to it by 
ligation with a short length of surgical silk suture. The nerve was then severed distal to 
electrode placement to prevent any possible trans-segmental feedback from the periphery. 
The exposed region was then bathed in mineral oil to prevent desiccation, and additional 
applications of mineral oil were administered periodically throughout recording. A 
ground wire was attached to the animal’s tail. Care was taken to attach both the 
stimulating and recording electrodes in the same locations in each animal. 
 A computer-based stimulation and recording system (SuperScope II; GWI, 
Somerville, MA) was used to drive an S48 stimulator (Grass, West Warwick, RI). The 
stimulus pulse was passed through a constant current unit (model PSIU6E; Grass) and a 
bipolar hook wire stimulating electrode (model PBCA0750; FHC). In order to record the 
actual current delivered during each stimulation, a current probe was attached between 
the constant current unit and the stimulating electrode. The signal from the recording 
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electrode was passed through an A-M Systems (Carlsborg, WA) differential AC amplifier 
(Model 1700), filtered (low: 300 Hz; high: 20 kHz), and amplified 1000X. Signals from 
both the current probe and the recording electrode were sent to an analog-to-digital 
acquisition device (InstruNet Model 100B; GWI, Somerville, MA) and recorded by 
SuperScope II at an acquisition rate of 10 kHz. Background activity of the motor nerve 
was recorded for approximately 13 msec before each stimulus pulse. Stimulus pulses 0.25 
ms long were generated once every 15 seconds, and resultant motor nerve activity was 
recorded for approximately 87 ms after each stimulus onset. In order to prevent 
polarization of the stimulating electrodes, current was temporarily reversed after every 33 
or 34 stimulus pulses (with recording suspended). For each animal, the threshold stimulus 
intensity and the stimulus intensity generating the maximum response were determined 
empirically. Stimulus intensity was then varied in order to sample from the entire range 
of effective stimulus intensities. Approximately 200 traces were generated for each 
animal. Following the completion of recording, animals were killed by an overdose of 
urethane and the BC and LA muscles were removed and weighed. 
Data Analysis 
 Response latency was determined by measuring the delay between the onset of 
the stimulus pulse at the dorsal root and the beginning of the first spike (defined as at 
least 10 times the rectified amplitude of the average background activity) in the motor 
nerve. Activity length was measured by determining the absolute amount of time between 
the beginning of the first spike and the end of the last spike following a stimulus pulse. In 
addition, the number of spikes generated following each stimulus pulse was counted. 
 61
 The maximum response of each animal was measured in two ways. First, the 
maximum peak-to-peak amplitude was determined in the unrectified data. Second, the 
traces were rectified and the maximum value for area under the curve was identified. 
Next, recruitment curves were constructed. Recruitment curves plot response magnitude 
as a function of stimulus intensity. Due to individual differences and minor changes in 
electrode placement, the range of stimulus intensities that produced a motor nerve 
response varied between animals. To minimize the effects of this variability, stimulus 
intensities were standardized across animals. This was accomplished by identifying for 
each animal the lowest stimulus intensity that produced a maximum response (the 
“lowest maximally effective stimulus”), then expressing all other stimulus intensities for 
that animal as a percentage of that stimulus intensity. Recruitment curves were 
constructed with the unrectified data using peak-to-peak amplitude as the measure of 
response magnitude, and with the rectified data using area under the curve as the measure 
of response magnitude. Because the maximum peak-to-peak response and the maximum 
area under the curve response for each animal were not always produced by the same 
stimulus pulse, the stimulus intensities were standardized separately in these two 
analyses. 
 To minimize the possibility of comparisons being affected by differences in motor 
unit recruitment, all measures were taken at high levels of stimulus intensity (except for 
response magnitudes measured during the construction of recruitment curves, which are 
by definition measured over the entire range of response-producing stimuli). Thus, 
response latencies were measured only for traces resulting from stimulus intensities at or 
above 90% of the lowest maximally effective stimulus (as determined by peak-to-peak 
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amplitude) for each animal. Similarly, average background activity, activity duration, and 
spike number were measured only for traces resulting from stimulus intensities between 
90% and 110% of the lowest maximally effective stimulus (as determined by peak-to-
peak amplitude) for each animal. 
 All results were analyzed by analyses of variance (one-way or repeated measures 
as appropriate) followed by post hoc analyses using Fisher’s least significant difference 
(LSD). 
RESULTS 
Muscle Weights 
 BC and LA muscle weights were recorded only for the saporin-injected groups. 
Unilateral saporin injection into the BC and LA muscles resulted in significant atrophy of 
the BC/LA on the injected side [compared to the non-injected side as an internal control; 
F(1, 8) = 48.17, p < .001; see Figure 4.2]. However, testosterone treatment increased 
BC/LA muscle weight on both the non-injected [0.672 ± 0.009 g for saporin-injected 
animals treated with testosterone compared to 0.575 ± 0.018 g for untreated saporin-
injected animals; F(1, 7) = 25.62, p < .01] and saporin-injected [0.527 ± 0.009 g for 
saporin-injected animals treated with testosterone compared to 0.423 ± 0.035 g for 
untreated saporin-injected animals; F(1, 7) = 10.25, p < .05] sides. 
Background Activity 
 Average background activity differed significantly by group [F(3, 16) = 7.68, p < 
.01; see Figure 4.3]. An examination of the individual data points reveals an outlier (see 
Figure 4.4). Of the five animals in the untreated saporin-injected group for whom 
background activity was recorded, one had a higher value than any other animal in any  
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FIGURE 4.2 
BC/LA muscle weights for untreated saporin-injected animals (filled bars) and saporin-
injected animals treated with testosterone (open bars), for both the recording (left) and 
saporin-injected (right) sides. Saporin injection decreased BC/LA weight, and treatment 
with exogenous testosterone increased BC/LA muscle weight. * indicates significant 
difference, p < .05. Bar heights represent means ± SEM. 
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FIGURE 4.3 
Average background activity for normal controls, untreated saporin-injected animals, 
saporin-injected animals treated with testosterone, and castrated controls. Average 
background activity varied significantly with group. Note that the variance of the 
untreated saporin-injected group is much larger than for any other group. Bar heights 
represent means ± SEM. 
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FIGURE 4.4 
Average background activity of individual normal controls, untreated saporin-injected 
animals, saporin-injected animals treated with testosterone, and castrated controls. Note 
the outlier in the untreated saporin-injected group that was higher than any other data 
point in any group. 
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group (4.72 µV). Removing that data point clarifies the effects of saporin and testosterone 
on average background activity (see Figure 4.5). Saporin injection significantly reduced 
average background activity (2.13 ± 0.07 µV for saporin-injected animals compared to 
3.30 ± 0.12 µV for normal controls; LSD, p < .001), and treatment with testosterone did 
not prevent this decrease (2.23 ± 0.12 µV for saporin-injected animals treated with 
testosterone, compared to normal controls; LSD, p < .001). Castration significantly 
increased average background activity (4.01 ± 0.13 µV for castrated controls, compared 
to normal controls; LSD, p < .001). 
Evoked Activity 
 In normal controls, activity produced by high intensity stimuli began 2.74 ± 0.34 
msec after delivery of the stimulus pulse, on average. However, response latency was 
significantly lengthened by saporin injection [4.93 ± 0.50 msec for saporin-injected 
animals; compared to normal controls, LSD, p < .001; overall test for the effect of group 
on response latency F(3, 16) = 12.58, p < .001; see Figure 4.6]. Treatment with 
testosterone did not attenuate saporin-induced increases in response latency (4.95 ± 0.43 
msec for saporin-injected animals treated with testosterone; compared to normal controls, 
LSD, p < .001). Castration had no effect on response latency (2.46 ± 0.21 msec for 
castrated controls; compared to normal controls, LSD, ns). 
 There were also differences in the duration of activity in response to high 
intensity stimulation [F(3, 16) = 3.60, p < .05; see Figure 4.7]. In normal controls, 
activity lasted for an average of 11.66 ± 1.30 msec, and never persisted for longer than 17 
msec. Saporin injection greatly increased activity duration (30.09 ± 6.97 msec for 
saporin-injected animals; compared to normal controls, LSD, p < .01), and only one  
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FIGURE 4.5 
Average background activity for normal controls, untreated saporin-injected animals, 
saporin-injected animals treated with testosterone, and castrated controls, with the outlier 
removed from the untreated saporin-injected group. Saporin injection decreased average 
background activity, and treatment with exogenous testosterone did not prevent this 
decrease. Castration alone increased average background activity. * indicates 
significantly different from normal controls, p < .001. Bar heights represent means ± 
SEM. 
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FIGURE 4.6 
Response latencies for normal controls, untreated saporin-injected animals, saporin-
injected animals treated with testosterone, and castrated controls. Saporin injection 
increased response latency, and treatment with exogenous testosterone did not prevent 
this. Castration alone had no effect on response latency. * indicates significantly different 
from normal controls, p < .001. Bar heights represent means ± SEM. 
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FIGURE 4.7 
Activity durations for normal controls, untreated saporin-injected animals, saporin-
injected animals treated with testosterone, and castrated controls. Saporin injection 
markedly increased activity duration. While the activity duration of testosterone-treated 
saporin-injected animals was not significantly different from that of normal controls, it 
was clearly closer to that of untreated saporin-injected animals. Castration alone had no 
effect on activity duration. * indicates significantly different from normal controls, p < 
.01. Bar heights represent means ± SEM. 
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saporin-injected animal had an activity duration of less than 17 msec. In saporin-injected 
animals treated with testosterone, activity duration was intermediate (23.32 ± 3.99 msec): 
while it was not significantly different from normal controls (LSD, p = .08), it clearly had 
more overlap with untreated saporin-injected animals. Activity duration in castrated 
controls (14.82 ± 3.36 msec) did not differ from normal controls (LSD, ns). Activity 
duration is defined as the amount of time between the first and last spikes, yet while there 
were significant group differences in activity duration, there weren’t any group 
differences in the number of spikes produced. High intensity stimulation resulted in an 
average of 12.66 ± 1.21 spikes, and this did not differ between groups [F(3, 16) = 1.21, 
ns]. 
 Maximum peak-to-peak response amplitude averaged 2.66 ± 0.49 mV, and this 
did not differ between groups [F(3, 17) = 0.40, ns]. Additionally, maximum peak-to-peak 
response amplitude was examined across stimulus intensity. As is expected for a 
recruitment curve, peak-to-peak response amplitude increased significantly with stimulus 
intensity [F(3, 36) = 16.15, p < .001]. However, there was no effect of group [F(2, 12) = 
0.33, ns] and no interaction between group and stimulus intensity [F(6, 36) = 0.70, ns]. 
 The maximum response as measured by area under the curve averaged 5.56 ± 
1.12 mV/msec, and this did not differ between groups [F(3, 17) = 1.13, ns]. Response 
size measured as area under the curve was also examined across stimulus intensities. As 
is expected for a recruitment curve, area under the curve increased significantly with 
stimulus intensity [F(3, 36) = 28.23, p < .001]. While the statistical analysis did not 
indicate a significant effect of group [F(2, 12) = 0.79, ns] or an interaction between group 
and stimulus intensity [F(6, 36) = 0.40, ns], examination of the graphical representation 
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of the recruitment curve suggests an effect of group (see Figure 4.8). It appears that 
saporin injection depressed SNB motoneuron activation. Moreover treatment with 
testosterone appears to have attenuated this depression, specifically at levels of stimulus 
intensity above 61% of the maximally effective stimulus. 
DISCUSSION 
Muscle Weights 
 Saporin injection decreased BC/LA muscle weight on the injected side of the 
muscle complex (Figure 4.2). This is consistent with the results of my previous studies 
(Fargo and Sengelaub, 2004a, 2004b) and the experiments reported in Chapters 3 and 6 
of this thesis. Testosterone treatment resulted in higher BC/LA weight on both the non-
injected and saporin-injected sides of the muscle. This serves as an important 
manipulation check in this experiment, given that testosterone treatment failed to prevent 
several changes in motor activation caused by saporin injection. 
 This protective effect of testosterone treatment on muscle weight is not always 
seen following saporin injection. In one previous experiment (Fargo and Sengelaub, 
2004a) testosterone treatment prevented atrophy of the saporin-injected muscles, while in 
another (Fargo and Sengelaub, 2004b) it did not. Given that the testosterone treatment 
was delayed in the former experiment, but immediate in the latter experiment, a 
reasonable question was whether the ability of testosterone to protect muscle weight 
following saporin injection was somehow tied to a delay between saporin injection and 
the onset of testosterone treatment. However, in the present experiment, testosterone 
treatment was immediate and still had a protective effect on muscle weight following 
saporin injection—this refutes the hypothesis that a delay between saporin injection and  
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FIGURE 4.8 
Recruitment curve illustrating the functional relationship between stimulus intensity and 
response magnitude. Data are shown for normal controls (filled circles), untreated 
saporin-injected animals (open circles), and saporin-injected animals treated with 
testosterone (triangles). Saporin injection attenuated SNB recruitment across the entire 
range of stimulus intensities. At high stimulus intensities, treatment with exogenous 
testosterone prevented this. Symbol heights represent means ± SEM. 
 73
testosterone treatment is necessary in order for testosterone to be effective in protecting 
muscle weight. 
Background Activity 
 Average background activity was recorded for approximately 13 msec before 
each stimulus pulse was delivered. Background activity was significantly reduced in 
saporin-injected animals, and treatment with testosterone did not prevent this (Figure 
4.5). In contrast, castration alone increased background activity significantly. This is the 
first ever report of experimental manipulation causing changes in SNB background 
activity. 
 Importantly, these data do not map neatly onto what is known about the effects of 
saporin injection and hormone treatments on SNB motoneuron morphology, in which 
castration and saporin injection produce similar regressive changes, and testosterone 
treatment prevents or reverses these changes. Several important conclusions can be drawn 
from this observation. First, although saporin injection and castration both lead to 
regressive morphological changes, each also results in its own unique changes to the 
SNB/BC system. This is not surprising in light of the fact that saporin injection kills a 
large portion of SNB motoneurons, whereas castration does not result in any cell death. 
Second, while this experiment grew out of the speculation that the regressive 
morphological consequences of saporin injection were likely to produce changes in 
SNB/BC electrophysiology, it is clear that saporin-induced changes in this system’s 
electrophysiology cannot be explained exclusively by morphological changes. Otherwise, 
saporin injection and castration could not have similar effects on morphology but 
opposite effects on background activity. Finally, while testosterone treatment has 
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powerful protective effects against saporin-induced dendritic regression, at least some of 
the electrophysiological consequences of saporin injection are not amenable to 
testosterone treatment. 
Evoked Activity 
 In intact animals, the first activity spike began approximately 2.7 msec after the 
stimulus pulse was delivered. Saporin injection increased response latency to nearly 5 
msec, and testosterone treatment did not prevent this increase in response latency (Figure 
4.6). Castration alone had no effect on response latency. These data suggest that central 
response latency is not controlled by testosterone. This finding is in agreement with a 
previous report that castration and testosterone replacement have no effect on SNB nerve 
conduction velocities or central delay (Tanaka and Arnold, 1993). This stands in stark 
contrast to the effect of testosterone on response latency in the peripheral motor 
components of the SNB system. When SNB motor axons are stimulated in the periphery 
and EMG is recorded at the BC muscle, response latency is increased by castration, and 
treatment with gonadal steroids prevents this increase (Fargo et al., 2003; Foster and 
Sengelaub, 2004b). The response latency data presented here provide another example of 
saporin causing changes to the electrophysiological properties of the SNB/BC system that 
are independent of its effects on morphology and not amenable to testosterone treatment. 
 The duration of activity was defined as the amount of time between the beginning 
of the first activity spike and the end of the last activity spike. Saporin injection increased 
activity duration, and testosterone did not effectively prevent this (Figure 4.7). Castration 
alone had no effect on activity duration. In contrast to activity duration, the actual number 
of spikes produced in response to stimulation was not different between groups, 
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suggesting that the activity was more spread out in the saporin-injected groups. Only two 
other reports of SNB activity duration or spike counts have been made. In the first, 
McKenna and Nadelhaft (1989) reported that non-spinalized animals exhibited what they 
called “later components” of the reflex, which appear to correspond to the spikes 
occurring late in the activity duration of animals in my saporin-injected groups. They 
reported, however, that these were invariably abolished by spinal transection. Given that 
all of my animals were spinally transected, it is difficult to judge exactly how the “later 
components” of McKenna and Nadelhaft relate to the increase in activity duration seen in 
my saporin-injected animals. In the second report (Fargo et al., 2003), the number of 
spikes in response to stimulation was decreased by castration, but maintained by 
concurrent treatment with estradiol. However, the experimental preparation in that study 
utilized a modified H-reflex setup, and spikes were counted for high-intensity 
stimulations. In the H-reflex setup, which involves both orthodromic and antidromic 
stimulation of motor axons, high-intensity stimulations tend to suppress reflex activity via 
afterhyperpolarization of the motoneurons. It is therefore possible that the reduced spike 
count associated with steroid withdrawal in that experiment was due to hormonal 
modulation of the inhibition of activity, rather than modulation of the underlying 
excitability of the system at rest. In light of the fact that castration had no effect on either 
activity duration or spike count in the current experiment, this seems like the most likely 
explanation. 
 Maximal responses, as measured by either peak-to-peak amplitude or area under 
the curve, did not differ between groups. However, the recruitment curve plotting 
response magnitude (as measured by area under the curve) against stimulus intensity 
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reveals that SNB recruitment is depressed by saporin injection, and that testosterone 
treatment prevents this depression at higher levels of stimulus intensity (Figure 4.8). 
Taken together, these data suggest that untreated saporin-injected animals maintain their 
ability to produce maximal responses, but the likelihood that they will produce a high 
magnitude response to any given stimulus is markedly decreased. Testosterone treatment, 
while not increasing the maximum response possible, increases the likelihood that the 
saporin-injected animal will produce a high magnitude response to a given stimulus.1
Functional correlate of testosterone’s protective effect on anatomy? 
 A clear pattern emerged in the electrophysiological data from this experiment: 
Saporin injection led to changes in several measures of central SNB electrophysiology; 
however, these changes were not prevented by hormone treatment. Saporin depressed 
average background activity, and increased both response latency and activity duration, 
and testosterone treatment had no effect on these measures. In fact, most of these 
measures seemed to be completely impervious to testosterone manipulation, as castration 
alone also had no effect on them (the lone exception is background activity, which is 
slightly increased by castration). This pattern is completely different from that seen in the 
morphology of SNB motoneurons: saporin injection and castration alone both lead to 
somal and dendritic atrophy, and testosterone treatment prevents these regressive 
changes. Therefore, there is no simple relationship between these measures of SNB motor 
function and testosterone’s protective effect on SNB morphology. 
                                                     
1 It is noteworthy that testosterone appears to be most effective in protecting SNB recruitment at high 
stimulus intensities and correspondingly high response magnitudes. Penile reflexes during copulatory 
behavior are mediated by a series of very strong contractions of the BC/LA muscle complex (Hart and 
Melese-D’Hospital, 1983). Therefore, protection of high response magnitudes would be expected to be 
more functionally relevant than protection of lower response magnitudes. 
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 Of course, it is highly unlikely that shrunken contralateral somata and dendritic 
arbors are the only neuroanatomical differences between normal controls and saporin 
injected animals. Saporin injection results in the death of ipsilateral motoneurons, and 
may also kill ipsilateral primary afferents. In addition, these losses are likely to result in 
the reorganization of other inputs into the surviving SNB motoneurons, such as those 
coming from interneurons. This hypothetical reorganization of the spinal reflex circuitry 
would be expected to give rise to changes to the electrophysiological response properties 
of the reflex, such as the changes in background activity, response latency, and activity 
duration reported here. Some of these hypothetical changes in neuroanatomy may not 
respond to testosterone treatment, and the electrophysiological changes arising from them 
would therefore also be expected to be unresponsive to testosterone treatment. 
 At least one measure of SNB electrophysiology, however, did appear to correlate 
with SNB somal and dendritic morphology following saporin injection. Saporin injection 
decreased SNB recruitment, and testosterone treatment prevented this decrease. This 
pattern of results exactly mirrors the protective effect of testosterone on the morphology 
of SNB motoneuron somata and dendrites following saporin injection. This suggests the 
possibility that recruitment is mediated at least in part by motoneuron morphology. One 
can easily imagine the increased surface area of larger somata and dendritic arbors 
providing sites for additional afferent input. However, based solely on the present data, 
one cannot conclude that SNB morphology directly impacts recruitment—only that the 
two change in concert following saporin injection and testosterone treatment. 
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Conclusions 
 The purpose of this experiment was to determine whether any 
electrophysiological changes accompany SNB motoneuron atrophy induced by 
contralateral saporin injection, and moreover, to determine whether treatment with 
exogenous testosterone would prevent these changes as it prevents motoneuron atrophy. 
Several measures of SNB electrophysiology were affected by saporin injection: average 
background activity, response latency, activity duration, and recruitment. Testosterone 
treatment restored recruitment to normal levels. These data indicate that the atrophy of 
SNB motoneurons caused by saporin injection is indeed accompanied by changes in their 
functional electrophysiology. More importantly, they demonstrate that testosterone 
treatment, in addition to restoring normal morphology, restores the ability of the system 
to produce normal responses at functionally relevant stimulation levels. 
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Chapter 5. 
 
Does Testosterone Protect against Regressive Changes in Motoneurons following Partial 
Motoneuron Depletion Induced by Ventral Root Avulsion? 
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 In previous experiments (Fargo and Sengelaub, 2004a, 2004b) I depleted SNB 
motoneurons by injection of a retrogradely transported toxin into their target musculature. 
This method has several advantages in terms of experimental control. First, it is 
neurotoxic regardless of hormone status (Fargo and Sengelaub, 2004a, 2004b). This is an 
important consideration because testosterone has been shown to protect neurons from cell 
death in several experimental paradigms. For example, testosterone prevents the death of 
cultured neurons following serum deprivation (Hammond et al., 2001), oxidative stress 
(Ahlbom et al., 2001), or exposure to β-amyloid (Pike, 2001); and in vivo, testosterone 
prevents neuron death in kainite-induced lesions (Ramsden et al., 2003). Because I am 
interested in testosterone’s protective effects on surviving motoneurons after depletion, it 
is important that my method of motoneuron depletion be effective even when the animal 
is treated with exogenous testosterone. Second, saporin injection is laterally specific, 
killing motoneurons only on the side of the spinal cord ipsilateral to the injected 
musculature (Fargo and Sengelaub, 2004a, 2004b). Saporin injection results in ipsilateral 
motoneuron depletion within the first week post-injection, and the number of surviving 
motoneurons does not change over the course of the next three weeks (Fargo and 
Sengelaub, 2004a), thus making it unlikely that contralateral SNB motoneurons are in the 
process of dying. That means that they can be used to determine what happens to the 
morphology of motoneurons whose counterparts have been depleted, but who are not 
themselves in the process of dying. 
 However, motoneuron depletion by saporin injection also has a potential 
drawback in that I am introducing a neurotoxin into the spinal cord. This raises the 
possibility that the morphological changes seen contralateral to the depletion are due to a 
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direct effect of saporin on those contralateral cells (or some other action of saporin in the 
spinal cord), instead of being due to the depletion of the ipsilateral cells. While the fact 
that motoneuron number stays constant contralaterally suggests that saporin is not killing 
contralateral motoneurons, it does not rule out the possibility that saporin is affecting 
them in some other way. Consequently, the protective effect of testosterone might be 
specific to situations in which a toxin is introduced into the spinal cord. 
 In order to test the generalizability of testosterone’s protective effect, it would be 
desirable to deplete motoneurons without the use of an exogenous neurotoxin1 and then 
treat with testosterone. In adult animals it is possible to kill substantial number of 
motoneurons by ventral root avulsion (VRA; Hoffmann and Thomeer, 1992; Koliatsos et 
al., 1994). In VRA, the ventral roots are physically separated from the spinal cord by 
pulling them away. This ruptures axons near or inside the spinal cord, puts the somata 
under physical strain, and results in the death of the majority of motoneurons whose 
axons occupy the avulsed roots. Therefore, VRA offers a laterally specific method to kill 
motoneurons without introducing an exogenous neurotoxin. Using VRA, then, can 
eliminate the possibility that the morphological changes seen in surviving motoneurons, 
and therefore the protective effect of testosterone, are related to the presence of an 
exogenous toxin. 
METHODS AND DESIGN 
 Adult male Sprague Dawley rats were used. Animals in the VRA groups were 
placed under general anesthesia with an intraperitoneal injection of Chlorapent (0.3 
ml/100 g body weight). Once animals no longer responded to pain, they were placed in 
                                                     
1 In developing animals this can be accomplished by muscle extirpation (Goldstein et al., 1993), but this 
method does not work in adults (e.g., Wu et al., 2003). 
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the prostrate position, and an incision of approximately 10 cm was made through the skin 
directly over, and parallel to, the spine. The skin was retracted with ophthalmic spreaders, 
and a scalpel was used to cut through the paraspinous muscles and connective tissue on 
the right side until the lateral aspect of the 2nd lumbar vertebra was completely exposed. 
The muscles and connective tissue were retracted with ophthalmic spreaders, and a few 
minutes were allowed to pass so that bleeding would subside before exposing the central 
nervous tissue. I then used rongeurs to create a small window approximately 4 to 5 mm 
long and 2 to 3 mm high in the right side of the 2nd lumbar vertebra. When this caused 
significant bleeding, the procedure was paused long enough for the bleeding to subside 
before continuing. The dural sheath was then cut along the length of the window, 
exposing the right side of the spinal cord and the right dorsal and ventral roots. The right 
ventral roots L5-S1 (which carry the SNB motoneurons’ axons) were located, and each 
was avulsed by the application of gentle traction caudally in a direction roughly parallel 
to their natural course. Once the ventral roots were separated from the spinal cord, a 
length of at least 1 cm of the distal stump was removed from each in order to prevent 
reinnervation. The window was then covered with a small piece of gelfoam to prevent the 
entry of blood into the cerebrospinal fluid. The muscles and connective tissue were then 
closed with silk sutures, and the skin closed with 9-mm AutoClips brand stainless steel 
wound clips. The animal was then allowed to recover from anesthesia. My technique is 
relatively unobtrusive compared to other root avulsion procedures, which are much more 
extensive yet have still been used without problem for survival times ranging up to 
several months (Blits et al., 2004; Gu et al., 2004; Gu et al., 2005; Hoang et al., 2003; 
Kishino et al., 1997). 
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 Coincident with ventral root avulsion, some animals were also simultaneously 
castrated and given replacement testosterone according the methods described in Chapter 
2 (VRA only n = 6, VRA and testosterone treatment n = 5). For the testosterone-treated 
animals, a testosterone implant was placed under the skin after closing the muscles and 
connective tissue but before closing the skin. A group of untreated intact normal males (n 
= 11) and a group of untreated castrates (n = 8) served as control groups. Four weeks 
after VRA and the onset of testosterone treatment, I injected HRP into the BC muscle on 
the left side (contralateral to the motoneuron depletion). The HRP injection was carried 
out according to the method described in Chapter 2. After two additional days to allow 
for optimal HRP transport, animals were killed and the perineal musculature removed 
and weighed according to the methods described in Chapter 2. Lumbosacral spinal cords 
were removed by laminectomy rather than the method described in Chapter 2, because 
laminectomy is less likely to damage the spinal roots. This allowed me to inspect each 
spinal cord to ensure the complete avulsion of ventral roots L5-S1. Spinal cords were 
then trimmed and processed for motoneuron counts and morphometry according to the 
methods described in Chapter 2. 
 Rostral dendritic extent was assessed by counting the number of sections between 
the most rostral HRP-labeled process and the most rostral HRP-labeled cell body. As the 
centers of these sections are 40 µm apart, the number of sections was multiplied by 40 
µm to arrive at an estimate of the actual linear distance spanned. Caudal dendritic extent 
was assessed in a similar fashion at the caudal end of the nucleus. 
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RESULTS 
Muscle Weights 
 The weight of the BC/LA muscle complex differed between groups on both the 
left (HRP-injected) and right (VRA) sides [left side F(3, 15) = 57.59, p < .001; right side 
F(3, 15) = 97.45, p < .001; see Figure 5.1]. Ventral root avulsion resulted in a drastic 
reduction in ipsilateral BC/LA weight (0.207 ± 0.016 g for VRA animals compared to 
0.606 ± 0.0301 g for normal controls; LSD, p < .001), and this was not prevented by 
testosterone treatment (0.300 ± 0.016 g for VRA animals treated with testosterone; 
compared to normal controls, LSD, p < .001). Muscle atrophy induced by ventral root 
avulsion was specific to the avulsed side (left side BC/LA muscle weights: 0.540 ± 0.022 
g for VRA animals, and 0.656 ± 0.034 g for VRA animals treated with testosterone, 
compared to 0.612 ± 0.030 g for normal controls; LSDs, ns]. Notably, treatment of VRA 
animals with testosterone increased BC/LA muscle weight on both sides of the animal 
(compared to VRA animals, LSD, ps < .01). Consistent with the previous literature 
(Eisenberg et al., 1949; Fargo and Sengelaub, 2004a; Wainman and Shipounoff, 1941), 
castration drastically reduced BC/LA weight (0.194 ± 0.007 g; compared to normal 
controls, LSD, p < .001). 
Cell Counts 
 Ventral root avulsion resulted in the death of over 65% of ipsilateral SNB 
motoneurons [38.00 ± 6.26 remaining motoneurons for VRA animals compared to 108.80 
± 11.34 for normal controls, LSD, p < .001; overall test for the effect of group on 
motoneuron number F(3, 15) = 32.90, p < .001; see Figure 5.2], and treatment with 
testosterone did not prevent this (20.80 ± 3.67 remaining motoneurons for VRA animals  
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FIGURE 5.1 
BC/LA muscle weights for normal controls, VRA animals, testosterone-treated VRA 
animals, and castrated controls, for both the root-avulsed side (open bars) and the non-
avulsed side (filled bars). Ventral root avulsion caused marked muscle atrophy, which 
was specific to the avulsed side and was not prevented by testosterone treatment. * 
indicates significantly different from normal controls, p < .001. † indicates significantly 
different from VRA animals, p < .01. Bar heights represent means ± SEM. 
Note: For normal controls and castrated controls, the open bars represent the right side 
and the filled bars represent the left side of the BC/LA muscle complex. 
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FIGURE 5.2 
Top: Brightfield photomicrograph of a transverse section through the lumbar spinal cord 
of a testosterone-treated VRA animal four weeks after unilateral avulsion of ventral roots 
L5-S1, showing three bilateral lumbosacral spinal nuclei: the retrodorsolateral nucleus 
(RDLN), the dorsolateral nucleus (DLN), and the SNB. Note the dearth of motoneurons 
on the avulsed (right) side of the spinal cord. Scale bar = 250 µm. Bottom: Numbers of 
thionin-stained SNB motoneurons in normal controls, VRA animals, testosterone-treated 
VRA animals, and castrated controls, for both the root-avulsed side (open bars) and the 
non-avulsed side (filled bars). Ventral root avulsion killed more than 65% of the 
ipsilateral SNB motoneurons, regardless of hormone status, and did not kill contralateral 
motoneurons. * indicates significantly different from normal controls, p < .001. Bar 
heights represent means ± SEM. 
Note: For normal controls and castrated controls, the open bars represent the right half 
and the filled bars represent the left half of the SNB. 
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treated with testosterone; compared to normal controls, LSD, p < .001). Consistent with 
the previous literature (Breedlove and Arnold, 1981; Fargo and Sengelaub, 2004a, 
2004b), castration did not result in the death of SNB motoneurons (98.67 ± 3.53 
remaining motoneurons for castrated controls; compared to normal controls, LSD, ns); 
the numbers of SNB motoneurons in both castrated and normal controls were well within 
the normal range. Importantly, SNB motoneuron death induced by ventral root avulsion 
was specific to the ipsilateral side: on the contralateral side, the average number of 
remaining motoneurons was 99.16 ± 6.41, and this did not differ between groups [F(3, 
15) = 0.32, ns] 
Morphometry 
 Somata 
 Soma areas for normal controls were 1068.71 ± 57.88 µm2. Castrated controls had 
somata of significantly smaller area, demonstrating the sensitivity of the measure (819.85 
± 55.29 µm2 for castrated controls; compared to normal controls, LSD, p < 01; overall 
test for the effect of group on soma area F(3, 20) = 5.02, p < .01; see Figure 5.3). 
However, neither VRA animals nor VRA animals treated with testosterone differed from 
normal controls in their soma areas (1030.66 ± 54.33 µm2 for VRA animals and 1033.88 
± 41.31 µm2 for VRA animals treated with testosterone; LSDs, ns). Somata were traced 
for an average of 21.14 ± 0.61 HRP-labeled motoneurons per animal, and this did not 
differ between groups [F(3, 17) = 1.60, ns]. 
 χ2 analysis of individual soma areas yielded similar results (see Figure 5.4). 
Castration shifted the distribution of individual soma areas toward the smaller end of the 
continuum [compared to normal controls, χ2(11) = 45.99, p < .001; overall test for the  
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FIGURE 5.3 
Soma areas of SNB motoneurons of normal controls, VRA animals, testosterone-treated 
VRA animals, and castrated controls. Castrated controls had smaller somata than the 
other groups, but neither VRA animals nor VRA animals treated with testosterone 
differed from normal controls. * indicates significantly different from normal controls, p 
< .001. Bar heights represent means ± SEM. 
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FIGURE 5.4 
Frequency distributions of individual soma areas of BC-projecting SNB motoneurons for 
normal controls, VRA animals, testosterone-treated VRA animals, and castrated controls. 
Only castrated controls had a frequency distribution different from that of normal 
controls, with castration shifting the distribution toward smaller somata. * indicates 
significantly different from normal controls, p < .001. 
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effect of group on the distribution of individual soma areas χ2(33) = 109.75, p < .001]. 
However, the frequency distributions of soma areas for VRA animals and VRA animals 
treated with testosterone did not differ from that of normal controls [χ2s(11) ≤ 13.57, ns]. 
 Dendrites 
 Injection of HRP into the left BC successfully labeled ipsilateral SNB 
motoneurons in a manner consistent with previous studies (Fargo and Sengelaub, 2004a, 
2004b; Kurz et al., 1991; Kurz et al., 1986). SNB motoneurons displayed their 
characteristic multipolar morphologies (Kurz et al., 1986; Sasaki and Arnold, 1991), with 
dendritic arbors projecting ventrolaterally, dorsomedially, and across the midline into the 
area of the contralateral SNB (Figure 5.5). An average of 78.10 ± 4.56 motoneurons per 
animal were labeled with HRP. 
 Dendritic length was an average of 5954.43 ± 640.11 µm, and group differences 
did not reach significance [F(3, 17) = 2.83, ns]. However, dendritic lengths for castrated 
controls (3145.60 ± 246.27 µm) were much smaller than for any other group2, and the 
dendritic lengths for the other three groups were very similar (7694.93 ± 1728.55 µm for 
normal controls, 6321.77 ± 1018.61 µm for VRA animals, and 6581.96 ± 1063.48 µm for 
VRA animals treated with testosterone; see Figure 5.6). In any case, the important result 
here is that the testosterone-treated animals are certainly no better off than the untreated 
VRA animals. 
 Dendritic length was nonuniform across radial bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 187) = 108.18, p < .001]. 
Consistent with the results of the arbor per cell analysis, there was no significant effect of 
                                                     
2 In fact, comparing only the normal controls and castrated controls suggests that castration did indeed 
cause a reduction in dendritic length [t(8) = 2.61, p < .05]. 
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FIGURE 5.5 
Left: Darkfield photomicrographs of transverse sections through the lumbar spinal cords 
of a normal control, a VRA animal, and a castrated control, after HRP injection into the 
left BC muscle. Right: Computer-generated composites of HRP-labeled somata and 
processes drawn at 320 µm intervals through the entire rostrocaudal extent of the SNB; 
these composites were selected because they are representative of their respective group 
average dendritic lengths. 
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FIGURE 5.6 
Dendritic lengths of SNB motoneurons of normal controls, VRA animals, testosterone-
treated VRA animals, and castrated controls. Although group differences did not reach 
statistical significance, a visual examination of the data indicates that castrated controls 
had shorter dendritic arbors than any other group, and that neither ventral root avulsion 
nor testosterone treatment had any effect on dendritic length. Bar heights represent means 
± SEM. 
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group [F(3, 17) = 2.83, ns], although castrated animals had smaller dendritic lengths than 
every other group in every radial bin and the other groups were all fairly similar. 
Specifically, castration reduced the length of the dendritic arbor by 65% from 0° to 30°, 
73% from 30° to 60°, 86% from 60° to 90°, 82% from 90° to 120°, 72% from 120° to 
150°, 56% from 150° to 180°, 46% from 180° to 210°, 43% from 210° to 240°, 50% from 
240° to 270°, 58% from 270° to 300°, 62% from 300° to 330°, and 75% from 330° to 
360° (see Figure 5.7).There was also a significant interaction between radial location and 
group [F(33, 187) = 2.69, p < .001, see Figure 5.7]; although there was no main effect of 
group, the dendritic lengths of VRA animals were shorter than those of normal controls 
in the most ventromedial portion of the spinal cord (240° to 300°), and testosterone 
treatment did not prevent this change. 
 Radial dendritic extent was nonuniform across bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 187) = 96.42, p < .001]. 
However, radial dendritic extent was not affected by VRA, testosterone treatment, or 
castration: it did not differ between groups [F(3, 17) = 1.60, ns], and there was no 
interaction between radial location and group [F(33, 187) = 0.80, ns; see Figure 5.8]. 
Similarly, both rostral and caudal dendritic extent were unaffected by VRA, testosterone 
treatment, or castration [rostral F(3, 17) = 0.65, ns; caudal F(3, 17) = 0.62, ns]. 
DISCUSSION 
Muscle Weights 
 Ventral root avulsion resulted in severe atrophy of the BC/LA musculature (see 
Figure 5.1). Notably, this atrophy was seen only on the side of the animal that received 
the avulsion, indicating that this manipulation is laterally specific in the periphery. This is 
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FIGURE 5.7 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB 
dendritic distribution. Bottom: Length per radial bin of SNB dendrites in normal controls, 
VRA animals, testosterone-treated VRA animals, and castrated controls. For graphic 
purposes, dendritic length measures have been collapsed into 6 bins of 60° each. SNB 
motoneuron dendritic arbors display a non-uniform distribution, with the majority of the 
arbor located between 180° and 300°. Although not reaching statistical significance, 
castration reduced dendritic length in every radial bin. In VRA animals, both untreated 
and testosterone-treated, dendritic length was reduced in the most ventromedial portion of 
the spinal cord (between 240° and 300°). * indicates major source of significant 
interaction between group and radial bin, p < .001. Bar heights represent means ± SEM. 
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FIGURE 5.8 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB radial 
dendritic extent. Bottom: Radial extents of SNB dendrites in normal controls, VRA 
animals, testosterone-treated VRA animals, and castrated controls. For graphic purposes, 
dendritic extent measures have been collapsed into 6 bins of 60° each. SNB dendritic 
extent is non-uniform across radial bins, and this non-uniform distribution is apparent in 
all groups. Bar heights represent means ± SEM. 
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important in establishing that any potential motoneuron atrophy on the intact side is not 
due simply to an effect of VRA on that side of the musculature. Castration also resulted 
in severe atrophy of the BC/LA muscles.3
 While testosterone treatment was not capable of fully restoring the weight of the 
muscles following VRA, testosterone-treated VRA animals had heavier muscles (on both 
sides) than untreated VRA animals. Rand and Breedlove (1992) reported that exogenous 
testosterone was ineffective in maintaining the weight of the denervated BC and LA. 
However, the data I report here suggest that their conclusion was premature—
testosterone can still affect the BC/LA musculature, even when they are disconnected 
from their innervating motoneurons. Moreover, testosterone also led to BC/LA 
hypertrophy on the intact side of the animal, again raising the possibility that testosterone 
treatment exerts its beneficial effects by acting through the musculature (but see Chapter 
6). 
Cell Counts 
 The purpose of the present experiment was to unilaterally deplete SNB 
motoneurons using a method that does not introduce an exogenous neurotoxin into the 
spinal cord, in order to determine whether the beneficial effects of testosterone generalize 
to those situations; I chose to accomplish this end by avulsing the ventral roots L5-S1. 
Ventral root avulsion resulted in the death of over 65% of the motoneurons in the 
ipsilateral SNB (Figure 5.2). This amount of motoneuron death is on par with that seen 
after saporin injection into the BC and LA (Fargo and Sengelaub, 2004a, 2004b; Chapter 
6), making VRA suitably lethal for the purposes of this experiment. Further, VRA-
                                                     
3 It is a demonstration of just how dependent these muscles are on androgens that castration resulted in 
almost the same level of atrophy as did complete denervation by VRA. 
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induced motoneuron death was specific to the side of the animal that underwent the 
avulsion—no motoneurons contralateral to the avulsion died. This means that we can 
examine the morphology of motoneurons whose contralateral neighbors have been 
depleted, but who are not themselves in the process of dying. 
 In order to interpret the results in terms of a potential beneficial effect of 
testosterone on motoneuron morphology following partial motoneuron depletion, it was 
critical that VRA result in ipsilateral motoneuron death even in the presence of 
exogenous testosterone. In some injury paradigms, treatment with exogenous steroids 
prevents motoneuron death ( e.g., Ahlbom et al., 2001; Hammond et al., 2001; 
Huppenbauer et al., 2005; Pike, 2001; Ramsden et al., 2003), and in fact, many protective 
substances, including some that are known to be regulated by androgens, have already 
been shown to prevent motoneuron death following VRA. These include nitroarginine 
(an inhibitor of nitric oxide synthase; Wu and Li, 1993), brain-derived neurotrophic 
factor (Blits et al., 2004; Chai et al., 1999; Kishino et al., 1997; Novikov et al., 1995; 
Novikov et al., 1997; Novikova et al., 1997; Wu et al., 2003), glial cell line-derived 
neurotrophic factor (Blits et al., 2004; Li et al., 1995; Wu et al., 2003), IGF-I (Haninec et 
al., 2003), GM1 ganglioside (Oliveira and Langone, 2000), T-588 (Ikeda et al., 2003), and 
Cerebrolysin (Haninec et al., 2003). It was therefore important to determine whether 
testosterone treatment prevented ipsilateral motoneuron death following VRA in the 
present experiment. The results indicate testosterone is completely ineffective in 
preventing motoneuron death following VRA (see Figure 5.2). This means that any 
potential beneficial effect of testosterone treatment on the morphology of the 
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contralateral motoneurons cannot be attributed to testosterone attenuating the motoneuron 
depletion induced by VRA. 
Morphometry 
 It has already been established that SNB motoneurons of untreated castrates 
undergo somal and dendritic atrophy (Araki et al., 1991; Breedlove and Arnold, 1981; 
Collins et al., 1992; Fargo and Sengelaub, 2004a; Forger et al., 1992; Jordan et al., 2002; 
Kurz et al., 1986; Sasaki and Arnold, 1991; Yang and Arnold, 2000a; Yang et al., 2004), 
and they are included in this experiment as a comparison group. Specifically, they offer 
evidence that my measurements are sensitive enough to detect changes in soma size and 
dendritic length. 
 Somata 
 In the present experiment, avulsion of the ventral roots L5-S1 did not result in 
changes to the size of contralateral SNB somata, so there was no somal atrophy for the 
testosterone treatment to prevent (Figures 5.3 and 5.4). The somata of normal controls, 
VRA animals, and testosterone-treated VRA animals were very similar. Because 
castrated controls had significantly smaller somata, it is unlikely that the lack of a VRA 
effect is due to the assay being insufficiently sensitive to detect a difference. The lack of 
a VRA effect on contralateral somata stands in contrast to depletion experiments using 
saporin injection (Fargo and Sengelaub, 2004a, 2004b; Chapter 6). Why VRA failed to 
result in the atrophy of contralateral SNB somata is an important question, and I will 
address it below. Because VRA did not result in somal atrophy, I cannot reach a 
conclusion as to whether testosterone’s neuroprotective effect following contralateral 
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motoneuron depletion generalizes to situations in which there is not an exogenous toxin 
introduced into the spinal cord. 
 Dendrites 
 Group differences in dendritic length failed to reach significance. However, from 
a visual examination of the data (Figure 5.6) it appears that castrated controls had clearly 
shorter dendritic arbors than any other group, while the other groups had very similar 
arbors.4 Additionally, previous studies have established that castration results in the 
marked atrophy of SNB dendrites (Fargo and Sengelaub, 2004a; Kurz et al., 1986; Sasaki 
and Arnold, 1991; Yang et al., 2004). In contrast, neither VRA nor testosterone treatment 
had any effect on dendritic length. As with soma size, this lack of an effect stands in 
contrast to depletion experiments using saporin injection (Fargo and Sengelaub, 2004a, 
2004b; Chapter 6) in which depletion resulted in severe dendritic retraction. Why VRA 
failed to result in the atrophy of contralateral SNB dendrites is an important question, and 
I will address it below. Because VRA did not result in dendritic atrophy, I cannot reach a 
conclusion as to whether testosterone’s neuroprotective effect following contralateral 
motoneuron depletion generalizes to situations in which there is not an exogenous toxin 
introduced into the spinal cord. 
 Analysis of the radial distribution of dendritic length revealed a significant 
interaction between group and location (Figure 5.7). Specifically, the dendritic length of 
VRA animals (regardless of testosterone treatment) is preferentially reduced in the most 
ventromedial portion of the spinal cord (240° to 300°). Interestingly, this happens to be 
                                                     
4 One might also speculate that VRA animals and testosterone-treated VRA animals had smaller dendritic 
arbors than normal controls, but that group differences were obscured by relatively large variances; 
however, the variances in these groups are not out of line with variances seen in previous experiments in 
which group differences in arbor per cell were statistically significant. 
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the portion of the spinal cord in which SNB motoneurons extend dendrites to connect 
with their contralateral counterparts. Perhaps the loss of contralateral SNB motoneurons 
results in a highly localized resculpting of the dendritic arbor, in which dendrites 
projecting to the now dead motoneurons are lost.5
 The possibility that saporin injection could depress retrograde transport of HRP 
and produce spuriously low measures of dendritic length in the castrated controls is an 
important consideration. However, measures of dendritic extent would also be affected 
by depression of retrograde transport, and in the current experiment radial extent (Figure 
5.8), rostral dendritic extent, and caudal dendritic extent were all unaffected by castration, 
making this unlikely. 
Why doesn’t VRA result in contralateral motoneuron atrophy? 
 The purpose of the present experiment was to test whether testosterone’s 
neuroprotective effects on motoneuron morphology generalize to situations in which 
partial motoneuron depletion occurs in the absence of an exogenous toxin. To that end, I 
used unilateral ventral root avulsion to kill the majority of ipsilateral SNB motoneurons, 
and simultaneously treated some of the experimental animals with testosterone. Four 
weeks after VRA, more than 65% of ipsilateral SNB motoneurons were dead. This result 
accords very closely with the results of depletion experiments using intramuscular 
saporin injection (Fargo and Sengelaub, 2004a, 2004b; Chapter 6), so I was very 
surprised that neither overall dendritic length nor soma area was reduced in these 
animals. Not only does the lack of an effect of VRA on SNB morphology leave me 
unable to determine whether testosterone’s benefits generalize, it also raises an 
                                                     
5 Note that in this case a highly localized resculpting might not necessarily be a pathological change, so the 
fact that treatment with testosterone does not prevent this does not necessarily argue against testosterone as 
a neurotherapeutic agent in this setup. 
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interesting question—why doesn’t motoneuron depletion by ventral root avulsion result in 
contralateral motoneuron atrophy? 
 The obvious difference between saporin injection and VRA is that VRA does not 
introduce a toxic substance into the spinal cord. Motoneurons that have been disrupted by 
ventral root avulsion undergo apoptosis (Haninec et al., 2003; Hoang et al., 2003; 
Koliatsos et al., 1994), a form of cell death that does not result in either the spillage of the 
cytoplasm into the extracellular milieu or an inflammatory response. The remains of cells 
that have undergone apoptosis are simply cleared from the area. In contrast, while saporin 
may impinge on certain apoptotic pathways (Bergamaschi et al., 1996; Narayanan et al., 
2005), its primary action is to inactivate ribosomes (Bergamaschi et al., 1996; Robertus 
and Monzingo, 2004; Stirpe, 2004). This leads to necrosis, a form cell death in which the 
cytoplasm is spilled into the extracellular space and which is typically followed by a 
strong local inflammatory response. These sequelae of necrosis might put stress on the 
surrounding tissues, including the contralateral motoneurons, thus resulting in 
contralateral motoneuron atrophy. Additionally, in this particular case, necrosis might 
result in the spilling of saporin into the extracellular space surrounding the surviving 
motoneurons. If this saporin remains in a biologically active state (Santanché et al., 
1997), it could potentially enter the surviving contralateral motoneurons or other neurons 
or glia that express GM1. In fact, Jasmin and colleagues (Jasmin et al., 2000; Jasmin and 
Ohara, 2004) have introduced saporin into the spinal cord by intrathecal perfusion, and 
have found that this leads to extensive death of glia, and over time, motoneurons. So it is 
possible that the atrophy observed in saporin injected animals is a result of saporin acting 
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directly on those motoneurons, rather than being secondary to the death, per se, of their 
contralateral counterparts. 
 Another difference between saporin injection and ventral root avulsion is that 
VRA may take longer than saporin to induce significant amounts of cell death. Data from 
my previous work (Fargo and Sengelaub, 2004a) indicate that saporin leads to massive 
cell death within the first week, and the number of surviving cells don’t change much 
between 1 and 4 weeks post injection. In contrast, VRA appears to lead to a slower, more 
progressive depletion of motoneurons (Wu, 1993). While Koliatsos et al. (1994) report 
seeing evidence of some cell death within 3 to 4 days following VRA, Hoang et al. 
(2003) report that it takes 1 week for 17% to die, 2 weeks for 54% to die, 4 weeks for 
78% to die, and 6 weeks for 84% to die. In addition, Gu et al. (2004) report seeing 
progressive death of motoneurons as far out as 20 weeks after VRA. Given that the 
motoneuron depletion induced by VRA is slower and more progressive than that seen 
after saporin injection, it is reasonable to wonder whether I would have seen contralateral 
atrophy had I waited a few more weeks after VRA to examine morphology.6 It is also 
possible that the slow, progressive nature of motoneuron loss following VRA allows the 
contralateral motoneurons to compensate for the loss, while the rapid nature of saporin-
induced motoneuron loss overwhelms their capacity to do so. 
 Another possible difference is that while VRA kills motoneurons, saporin injected 
into the muscles may kill afferents as well as motoneurons. While this is purely 
speculative, it raises the interesting possibility that contralateral somal and dendritic 
atrophy, which are seen following saporin injection but not VRA, are induced by 
                                                     
6 It is also interesting to speculate about the localized dendritic retraction seen in root-avulsed animals 
between 240° and 300° (Figure 5.6); perhaps that is simply the first stage of a full-blown atrophy beginning 
to occur as more and more motoneurons die in the weeks following VRA. 
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deafferentation rather than by the death of motoneurons, per se. One simple way to test 
this hypothesis would be to perform dorsal root avulsions. If saporin-induced somal and 
dendritic atrophy arise from deafferentation, then dorsal root avulsions would be 
expected to cause similar atrophy while ventral root avulsions would not. 
Conclusions 
 The purpose of this experiment was to determine whether testosterone would have 
a protective effect on motoneuron morphology following contralateral motoneuron 
depletion by a method that does not introduce a toxin into the spinal cord. Ventral root 
avulsion was chosen because it is known to kill the vast majority of motoneurons 
ipsilateral to the injury. While VRA was successful in killing motoneurons unilaterally, I 
did not observe any contralateral motoneuron atrophy. Because of this, it is impossible to 
reach a conclusion as to the generalizability of testosterone’s neuroprotective effects. 
Additional experiments need to be carried out to determine whether contralateral 
motoneurons would display atrophy at longer time points or following dorsal root 
avulsion. If they do, then testosterone treatment could be employed to see whether it is 
neuroprotective in that situation. 
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Chapter 6. 
 
Is Testosterone’s Protective Effect on Surviving Motoneurons 
an Androgen Effect or an Estrogen Effect? 
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 My previous studies (Fargo and Sengelaub, 2004a, 2004b) demonstrated that 
testosterone is neuroprotective following unilateral saporin injection. I have discussed 
this in terms of testosterone’s role as an androgen. However, testosterone also acts on 
estrogenic systems by aromatization to estradiol. Additionally, both androgens and 
estrogens have protective qualities in the nervous system (Bialek et al., 2004; Henderson 
and Reynolds, 2002). It is therefore important to determine whether the effect of 
testosterone in protecting surviving motoneurons is an estrogen effect or an androgen 
effect. 
 The anatomy of the SNB/BC neuromuscular system has traditionally been thought 
of as primarily androgen-dependent. SNB motoneurons contain high levels of both 
androgen receptors (Breedlove and Arnold, 1980) and 5α-reductase (the enzyme that 
converts testosterone into the powerful androgen dihydrotestosterone; Pozzi et al., 2003), 
as well as steroid receptor coactivators (O'Bryant and Jordan, 2005; Ranson et al., 2003), 
all of which suggest that these motoneurons are direct androgen targets. Additionally, 
androgens maintain a wide variety of SNB motoneuron characteristics, including soma 
size (Breedlove and Arnold, 1981) and dendritic length (Kurz et al., 1986), the number 
and size of synapses (Leedy et al., 1987; Matsumoto, 2005; Matsumoto et al., 1988b) and 
gap junction plaques (Matsumoto et al., 1988a), and the percentage of membrane 
contacted by glia (Leedy et al., 1987). Moreover, the SNB target musculature contains 
high numbers of androgen receptors (Monks et al., 2004); and androgens maintain a 
variety of characteristics of these muscles, including weight (Wainman and Shipounoff, 
1941), fiber size (Venable, 1966), neuromuscular junction size (Balice-Gordon et al., 
1990; Bleisch and Harrelson, 1989), acetylcholine receptor number (Bleisch and 
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Harrelson, 1989; Bleisch et al., 1982), muscle excitability (Foster and Sengelaub, 2004b), 
and the number of functional calcium channels at the neuromuscular junction (Nudler et 
al., 2005). 
 Androgens also regulate several important biochemicals in the adult rat SNB/BC 
neuromuscular system. For example, levels of immunoreactivity for the ciliary 
neurotrophic factor receptor α are androgen-dependent in SNB motoneurons (Forger et 
al., 1998), as are levels of mRNA expression for the major cytoskeletal elements β-actin 
(Matsumoto et al., 1992) and β-tubulin (Matsumoto et al., 1993). Additionally, androgen 
manipulation affects levels of gap junction mRNA expression (Matsumoto et al., 1991; 
Matsumoto et al., 1992), N-cadherin immunoreactivity (Monks et al., 2001), calcitonin 
gene-related peptide immunoreactivity (Popper and Micevych, 1989) and mRNA 
expression (Popper and Micevych, 1990), androgen receptor immunoreactivity 
(Matsumoto et al., 1996), and BCL-2 immunoreactivity (Zup and Forger, 2002) in SNB 
motoneurons. 
 However, the SNB/BC neuromuscular system is not regulated solely by 
androgens. The target muscles of the SNB also contain an estrogen-binding protein 
(presumably an estrogen receptor; Dubé et al., 1976), and estradiol plays a powerful role 
in this system. For example, the reflexes of this system are maintained by estradiol 
following castration (O'Hanlon et al., 1981). In addition, Holmes and Sachs (1992) found 
that estradiol was as effective as testosterone in maintaining EMG activity of the BC 
during copulation. Estradiol-treated castrates displayed spontaneous erections during 
copulatory testing, and produced in copula reflexive BC EMG activity similar to that of 
intact males and testosterone-treated castrates. Estradiol also maintains the motor 
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excitability of the SNB/BC in response to nerve stimulation (Fargo et al., 2003; Foster 
and Sengelaub, 2004b). Finally, estradiol is necessary for the development of normal 
motoneuron morphology in the SNB (Burke et al., 1999; Burke et al., 1997; Goldstein 
and Sengelaub, 1994; Hebbeler et al., 2001). 
 Given this system’s responsiveness to both androgens and estrogens, and given 
that testosterone can act as an androgen or be metabolized into either an androgen or an 
estrogen (both of which exert neuroprotective effects in the CNS), it is important to 
determine whether the effect of testosterone in maintaining SNB motoneuron 
morphology following saporin injection is an androgen effect or an estrogen effect. The 
purpose of the present experiment is to make this discrimination by injecting animals 
with saporin, then treating them with either estradiol or the non-aromatizable androgen 
dihydrotestosterone. 
METHODS AND DESIGN 
 Adult male Sprague Dawley rats were used. Saporin injections were made into the 
BC and LA muscles according to the method described in Chapter 2 (saporin only n = 8). 
Coincident with saporin injection, some animals were also given replacement 
hormones—testosterone, dihydrotestosterone, or estradiol. Testosterone implants were 
made and administered according the methods described in Chapter 2 (saporin and 
testosterone treatment n = 8). Dihydrotestosterone (DHT) implants were made in the 
same fashion as testosterone implants with the exception that the diffusion surface of the 
implant was 30 mm long instead of 45 mm long. This length was chosen because DHT 
implants of this size and even smaller have been used with robust results in previously 
published studies (Forger et al., 1992; Meisel et al., 1984; Monks et al., 2001). In 
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addition, this laboratory has previously used 30-mm DHT implants to successfully 
maintain dendritic length following castration (unpublished observations), further 
increasing my confidence that this length would dispense a sufficient amount of DHT to 
demonstrate an effect. DHT was chosen because it exerts its effects through the androgen 
receptor, and it cannot be aromatized into estradiol; therefore, if DHT has an effect, it 
will not be attributable to conversion to estradiol (saporin and DHT treatment n = 8). 
 In contrast to androgen treatment, estrogen treatment was given in the form of 
subcutaneous injections of hormone dissolved in sesame oil. Estradiol-treated animals 
received daily injections beginning on the day of saporin injection and castration. Each 
injection consisted of 300 µg estradiol benzoate (Steraloids, Inc.; Wilton, NH) dissolved 
in 0.15 ml of sesame oil (saporin and estradiol treatment n = 7). This dose was chosen 
because I have previously used it to successfully maintain electrophysiological activity at 
normal levels in castrated males (Fargo et al., 2003; also see Holmes and Sachs, 1992). 
Oil-based injections were chosen over Silastic implants because oil-based injections have 
previously been used to successfully mediate SNB dendritic morphology in rats (Burke et 
al., 1997; Goldstein and Sengelaub, 1994; Hebbeler and Sengelaub, 2003); in contrast, I 
am unaware of any previous studies demonstrating an effect of Silastic estradiol implants 
on motoneuron morphology. Estradiol benzoate is a physiologically active ester of 
estradiol. When administering hormones in oil, hormone esters are typically used in place 
of standard hormones; because they are strongly hydrophobic they stay dissolved in the 
oil vehicle longer and thus provide a more steady level of hormone throughout the day 
(Smith et al., 1977). A group of untreated intact normal males served as a control group 
(n = 11). 
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 It should be noted that no animals were castrated in this experiment. This is a 
departure from previous experiments, in which hormone-treated animals were castrated. 
As discussed in Chapter 2, the purpose of castration in those animals was to improve 
experimenter control over hormone levels by eliminating one source of inter-individual 
variation in hormone levels, namely, the amount of hormones produced by each animal’s 
gonads. However, the purpose of the present experiment was to determine whether 
treatment with testosterone or its immediate metabolites, DHT and estradiol, would 
prevent saporin-induced dendritic atrophy. Previous experiments (unpublished data from 
this laboratory) have demonstrated that estradiol treatment is insufficient to prevent or 
reverse castration-induced dendritic retraction. For this reason, if the estradiol-treated 
animals in this experiment had been castrated, it would have been impossible to 
determine whether any potential dendritic atrophy was caused by the castration or by an 
inability of estradiol to prevent saporin-induced atrophy. In addition, the fact that this 
experimental design does not include castration allows me to determine whether 
androgen treatment is effective in preventing saporin-induced dendritic atrophy in 
gonadally intact animals. 
 Four weeks after saporin injection and hormone-treatment onset, I injected HRP 
into the contralateral BC muscle according to the method described in Chapter 2. After 
two additional days to allow for optimal HRP transport, animals were killed and the 
perineal musculature removed and weighed. Lumbosacral spinal cords were removed and 
processed for motoneuron counts and morphometry according to the methods described 
in Chapter 2. 
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RESULTS 
Muscle Weights 
 Unilateral injection of saporin into the BC/LA muscle complex resulted in marked 
atrophy of the injected musculature [0.444 ± 0.016 g for saporin-injected animals 
compared to 0.606 ± 0.030 g for normal controls, LSD, p < .001; overall test for the 
effect of group on right side muscle weight F(4, 30) = 49.47, p < .001; see Figure 6.1], 
and hormone treatment did not prevent this (right side muscle weights were 0.514 ± 
0.021 g for saporin-injected animals treated with testosterone, 0.189 ± 0.013 g for 
saporin-injected animals treated with estradiol, and 0.424 ± 0.024 g for saporin-injected 
animals treated with DHT; compared to normal controls, LSD, ps < .01). However, while 
none of the various hormone treatments completely prevented saporin-induced reductions 
in muscle weight, they did have differential effects: testosterone increased muscle weight 
to some extent while estradiol further decreased it (compared to untreated saporin-
injected animals; LSD, ps < .05), and DHT had no effect (compared to untreated saporin-
injected animals; LSD, ns). Notably, the effect of saporin injection on BC/LA weight was 
specific to the injected side of the muscle complex [left side muscle weights were 0.603 ± 
0.017 g for saporin-injected animals and 0.612 ± 0.030 g for normal controls, LSD, ns; 
overall test for the effect of group on left side muscle weight F(4, 30) = 50.59, p < .001; 
see Figure 6.1]. The various hormone treatments had differential effects on left side 
muscle weights also: testosterone increased muscle weight (0.727 ± 0.039 g for saporin-
injected animals treated with testosterone; compared to untreated saporin-injected 
animals, LSD, p < .01) while estradiol decreased it markedly and DHT decreased it a 
small amount (0.243 ± 0.016 g for saporin-injected animals treated with estradiol, and  
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FIGURE 6.1 
BC/LA muscle weights for normal controls, untreated saporin-injected animals (SAP), 
saporin-injected animals treated with testosterone (SAP+T), saporin-injected animals 
treated with estradiol (SAP+E), and saporin-injected animals treated with the non-
aromatizable androgen dihydrotestosterone (SAP+DHT). * indicates significantly 
different from normal controls, p < .05. † indicates significantly different from untreated 
saporin-injected animals, p < .05. Bar heights represent means ± SEM. Open bars: Open 
bars represent the saporin-injected side of the muscle complex. Saporin injection 
decreased muscle weight on the injected side. Steroid treatments had differential effects. 
Testosterone increased muscle weight, but only partially attenuated the effect of saporin 
injection. Estradiol actually decreased muscle weight even more than saporin injection 
alone. DHT neither increased nor decreased muscle weight compared to saporin injection 
alone. Filled bars: Filled bars represent the HRP-injected side of the muscle complex. 
Saporin injection into the contralateral side had no effect on this side of the muscle. 
Steroid treatments had differential effects. Testosterone increased muscle weight above 
normal. In contrast, both estradiol and DHT reduced muscle weight, with estradiol having 
a much larger effect than DHT. 
Note: For normal controls, the open bars represent the right (non-injected) side and the 
filled bars represent the left (HRP-injected) side of the BC/LA muscle complex.
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0.520 ± 0.019 g for saporin-injected animals treated with DHT; compared to untreated 
saporin-injected animals, LSD, ps < .05). 
Cell Counts 
 The number of SNB motoneurons in normal controls was well within the normal 
range (108.80 ± 11.34). Injection of saporin into the BC/LA muscle complex resulted in 
the death of over 60% of ipsilateral SNB motoneurons [42.00 ± 5.07 remaining 
motoneurons for saporin-injected animals; compared to normal controls, LSD, p < .001; 
overall test for the effect of group on motoneuron number F(4, 25) = 17.25, p < .001; see 
Figure 6.2], and hormone treatment did not prevent this (34.67 ± 6.42 remaining 
motoneurons for saporin-injected animals treated with testosterone, 32.00 ± 4.73 
remaining motoneurons for saporin-injected animals treated with estradiol, and 33.33 ± 
8.98 remaining motoneurons for saporin-injected animals treated with DHT; compared to 
normal controls, LSD, ps < .001). Importantly, SNB motoneuron death induced by 
saporin injection was specific to the ipsilateral side: on the contralateral side, the average 
number of remaining motoneurons was 92.27 ± 5.19, and this did not differ between 
groups [F(4, 25) = 0.08, ns] 
Morphometry 
 Somata 
 Somata were traced for an average of 22.50 ± 0.73 HRP-labeled motoneurons per 
animal, and this did not differ between groups [F(4, 23) = 1.35, ns]. Injection of saporin 
into the BC/LA muscle complex resulted in the atrophy of contralateral SNB 
motoneurons. Soma areas decreased by approximately 20% [875.44 ± 44.69 µm2 for 
saporin-injected animals compared to 1068.71 ± 57.88 µm2 for normal controls, LSD, p <  
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FIGURE 6.2 
Numbers of thionin-stained SNB motoneurons for normal controls, untreated saporin-
injected animals (SAP), saporin-injected animals treated with testosterone (SAP+T), 
saporin-injected animals treated with estradiol (SAP+E), and saporin-injected animals 
treated with the non-aromatizable androgen dihydrotestosterone (SAP+DHT), for both 
the saporin-injected side (open bars) and the HRP-injected side (filled bars). Saporin 
killed more than 60% of the ipsilateral SNB motoneurons, regardless of hormone status, 
and did not kill contralateral motoneurons. * indicates significantly different from normal 
controls, p < .001. Bar heights represent means ± SEM. 
Note: For normal controls, the open bars represent the right half and the filled bars 
represent the left half of the SNB. 
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.05; overall test for the effect of group on soma area F(4, 23) = 4.46, p < .01; see Figure 
6.3]. However, treatment with androgens prevented this atrophy (921.44 ± 48.09 µm2 for 
saporin-injected animals treated with testosterone, and 934.41 ± 50.80 µm2 for saporin-
injected animals treated with DHT; compared to normal controls, LSDs, ns). In contrast, 
treatment with estradiol was completely ineffective in protecting contralateral SNB 
motoneurons from saporin-induced reductions in soma area (750.49 ± 58.06 µm2 for 
saporin-injected animals treated with estradiol; compared to normal controls, LSD, p < 
.001) 
 Dendrites 
 Injection of HRP into the left BC successfully labeled ipsilateral SNB 
motoneurons in a manner consistent with previous studies (Fargo and Sengelaub, 2004a, 
2004b; Kurz et al., 1991; Kurz et al., 1986). SNB motoneurons displayed their 
characteristic multipolar morphologies (Kurz et al., 1986; Sasaki and Arnold, 1991), with 
dendritic arbors projecting ventrolaterally, dorsomedially, and across the midline into the 
area of the contralateral SNB (Figure 6.4). An average of 50.57.10 (± 3.96) motoneurons 
per animal were labeled with HRP. 
 Injection of saporin into the BC/LA muscle complex resulted in the marked 
atrophy of contralateral SNB motoneuron dendrites. Dendritic length decreased by more 
than 65% (2589.31 ± 399.26 µm for saporin-injected animals compared to 7694.93 ± 
1728.55 µm for normal controls, LSD, p < .01; overall test for the effect of group in arbor 
per cell F(4, 23) = 4.66, p < .01; see Figure 6.5]. However, treatment with androgens 
prevented this dendritic atrophy (5234.49 ± 1195.14 µm for saporin-injected animals 
treated with testosterone, and 7181.43 ± 1435.71 µm for saporin-injected animals treated  
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FIGURE 6.3 
Cross-sectional soma areas of SNB motoneurons for normal controls, untreated saporin-
injected animals (SAP), saporin-injected animals treated with testosterone (SAP+T), 
saporin-injected animals treated with estradiol (SAP+E), and saporin-injected animals 
treated with the non-aromatizable androgen dihydrotestosterone (SAP+DHT). Saporin 
injection decreased contralateral soma size by approximately 20%. Treatment with either 
testosterone or DHT prevented this decrease, but treatment with estradiol was completely 
ineffective. * indicates significantly different from normal controls, p < .05. Bar heights 
represent means ± SEM. 
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FIGURE 6.4 
Left: Darkfield photomicrographs of transverse sections through the lumbar spinal cords 
of saporin-injected animals treated with testosterone, estradiol, or DHT, after HRP 
injection into the left BC muscle. Right: Computer-generated composites of HRP-labeled 
somata and processes drawn at 320 µm intervals through the entire rostrocaudal extent of 
the SNB; these composites were selected because they are representative of their 
respective group average dendritic lengths.
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FIGURE 6.5 
Dendritic lengths of SNB motoneurons of normal controls, untreated saporin-injected 
animals (SAP), saporin-injected animals treated with testosterone (SAP+T), saporin-
injected animals treated with estradiol (SAP+E), and saporin-injected animals treated 
with the non-aromatizable androgen dihydrotestosterone (SAP+DHT). Saporin injection 
caused a greater than 65% reduction in dendritic length. Treatment with either 
testosterone or the non-aromatizable androgen DHT prevented this dendritic atrophy. In 
contrast, treatment with estradiol was completely ineffective. * indicates significantly 
different from normal controls, p < .01. Bar heights represent means ± SEM. 
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with DHT; compared to normal controls, LSDs, ns]. In contrast, treatment with estradiol 
was completely ineffective in protecting contralateral SNB motoneurons from saporin-
induced dendritic atrophy (2193.08 ± 384.16 µm for saporin-injected animals treated with 
estradiol; compared to normal controls, LSD, p < .01). 
 Dendritic length was nonuniform across radial bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 253) = 111.39, p < .001; 
see Figure 6.6]. Consistent with the results of the arbor per cell analysis, there was also a 
significant effect of group [F(4, 23) = 4.75, p < .01]. Saporin injection led to reductions 
in arbor length of approximately 91% from 0° to 30°, 90% from 30° to 60°, 93% from 
60° to 90°, 94% from 90° to 120°, 90% from 120° to 150°, 87% from 150° to 180°, 79% 
from 180° to 210°, 30% from 210° to 240°, 44% from 240° to 270°, 79% from 270° to 
300°, 88% from 300° to 330°, and 93% from 330° to 360°. Treatment with either 
testosterone or the non-aromatizable androgen DHT blocked these reductions, but 
treatment with estradiol did not (see Figure 6.6). 
 Dendritic extent was nonuniform across radial bins, and repeated-measures 
ANOVA revealed a significant effect of radial location [F(11, 253) = 100.81, p < .001]. 
There was also a significant effect of group [F(4, 23) = 7.90, p < .001]. Radial dendritic 
extent was depressed in both untreated saporin-injected animals and in saporin-injected 
animals treated with estradiol (compared to normal controls; LSD, ps < .05). Only 
treatment with DHT completely protected SNB motoneurons from saporin-induced loss 
of radial dendritic extent (compared to normal controls; LSD, ns). While the radial 
dendritic extent of testosterone-treated saporin-injected animals was still significantly 
smaller than that of normal controls (LSD, p < .05), an examination of the data makes it  
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FIGURE 6.6 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB 
dendritic distribution. Bottom: Length per radial bin of SNB dendrites in normal controls, 
untreated saporin-injected animals (SAP), saporin-injected animals treated with 
testosterone (SAP+T), saporin-injected animals treated with estradiol (SAP+E), and 
saporin-injected animals treated with the non-aromatizable androgen dihydrotestosterone 
(SAP+DHT). For graphic purposes, dendritic length measures have been collapsed into 6 
bins of 60° each. SNB motoneuron dendritic arbors display a non-uniform distribution, 
with the majority of the arbor located between 180° and 300°. Saporin injection and 
castration each reduced dendritic length in every bin. Treatment with testosterone or 
DHT effectively blocked this reduction, but treatment with estradiol did not. * indicates 
significantly different from normal controls, p < .01. Bar heights represent means ± SEM. 
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clear that testosterone treatment partially attenuated the effects of saporin injection in 
every radial bin (see Figure 6.7). There was no significant interaction between radial 
location and group [F(44, 253) = 1.16, ns]. 
 Rostrocaudal dendritic extent also varied by group [F(4, 23) = 3.30, p < .05; see 
Figure 6.8]. However, post hoc comparisons revealed that no group differed significantly 
from normal controls (3008.00 ± 259.97 µm for normal controls, 2586.67 ± 167.39 µm 
for untreated saporin-injected animals, 3253.33 ± 114.39 µm for saporin-injected animals 
treated with testosterone, 2624.00 ± 129.98 µm for saporin-injected animals treated with 
estradiol, and 3200.00 ± 184.75 µm for saporin-injected animals treated with DHT; 
LSDs, ns). 
DISCUSSION 
Muscle Weights 
 Given the hypothesis that testosterone might exert its beneficial effects on 
motoneuron morphology by acting through the muscle, the muscle weight results are of 
particular interest (Figure 6.1). The first thing that should be noted is that saporin 
injection decreased the weight of the injected side of the muscle complex in every group. 
Second, in the untreated saporin-injected animals, saporin injection had no effect on the 
weight of the contralateral muscles. These results provide a verification that saporin 
injections occurred as planned. Specifically, they increase our confidence that saporin did 
not diffuse across the midline in the periphery in any significant amount. 
 Testosterone and its metabolites had very different effects on muscle weights 
(Figure 6.1). Testosterone was the most trophic of the three—it increased the weight of 
the non-injected muscle above normal, and partially ameliorated the atrophy induced by  
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FIGURE 6.7 
Top: Drawing of spinal gray matter divided into radial sectors for measure of SNB radial 
dendritic extent. Bottom: Radial extents of SNB dendrites in normal controls, untreated 
saporin-injected animals (SAP), saporin-injected animals treated with testosterone 
(SAP+T), saporin-injected animals treated with estradiol (SAP+E), and saporin-injected 
animals treated with the non-aromatizable androgen dihydrotestosterone (SAP+DHT). 
For graphic purposes, dendritic extent measures have been collapsed into 6 bins of 60° 
each. Saporin injection depressed SNB dendritic extent across radial bins. Treatment with 
DHT completely prevented this. Testosterone appeared to partially prevent the loss of 
radial dendritic extent (but this was not statistically significant; see text). Estradiol was 
completely ineffective in preventing decreases in radial dendritic extent. * indicates 
significantly different from normal controls, p < .05. Bar heights represent means ± SEM. 
 122
  
 
Normal SAP SAP+T SAP+E SAP+DHT
R
O
S
TR
O
C
A
U
D
A
L
D
E
N
D
R
IT
IC
E
X
TE
N
T
(µ
m
)
0
1000
2000
3000
4000
 
 
 
FIGURE 6.8 
Rostrocaudal extents of SNB dendrites in normal controls, untreated saporin-injected 
animals (SAP), saporin-injected animals treated with testosterone (SAP+T), saporin-
injected animals treated with estradiol (SAP+E), and saporin-injected animals treated 
with the non-aromatizable androgen dihydrotestosterone (SAP+DHT). While an ANOVA 
revealed a main effect of group on rostrocaudal dendritic extent, no group differed 
significantly from normal controls. Bar heights represent means ± SEM. 
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saporin in the injected muscle. In contrast, DHT had no beneficial effect on the weight of 
the saporin injected muscles, and even resulted in a small but significant loss of weight in 
the non-injected muscles. Given that DHT is an androgen and an anabolic steroid, it 
would seem unusual for it to actually cause muscle atrophy. In fact, it has previously 
been reported that DHT maintains BC/LA muscle weight in castrated animals over at 
least the first 10 days post-castration (Foster and Sengelaub, 2004b). However, the 
muscle weight data from Forger et al. (1992) and unpublished data from our laboratory 
independently confirm that BC and LA muscle weights are better maintained by 
testosterone than by DHT over longer periods. It is therefore likely that DHT treatment 
decreased muscle weight in these animals by depressing testosterone levels via a negative 
feedback loop, inhibiting the HPG axis. Finally, estradiol treatment dramatically reduced 
BC/LA muscle weights. Again, this is probably secondary to a depression of testosterone 
levels via negative feedback. The marked loss of muscle weight in the estradiol-treated 
animals is especially interesting in light of the fact that estradiol treatment has been 
shown to protect electrophysiological activity of the BC and LA by acting on peripheral 
structures (Fargo et al., 2003; Foster and Sengelaub, 2004b). It therefore seems that 
estradiol acts on some peripheral component of the SNB system that is independent of 
muscle weight. 
Cell Counts 
 Unilateral saporin injection resulted in the death of over 60% of ipsilateral 
motoneurons (Figure 6.2). Furthermore, saporin injection resulted in a laterally specific 
depletion of SNB motoneurons—motoneuron number contralateral to saporin injection 
did not differ from normal. As previously mentioned, in some model preparations, steroid 
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hormones prevent injury-induced neuron death. It was therefore important to establish 
that saporin injection killed approximately the same number of motoneurons in the 
untreated and steroid-treated groups. As can be clearly seen in Figure 6.2, saporin 
injection was equally effective in killing motoneurons in all saporin-injected groups, 
regardless of hormone treatment. This means that any potential beneficial effects of 
steroid treatment on contralateral motoneuron morphology cannot be explained simply by 
an attenuation of saporin’s ability to kill ipsilateral motoneurons. 
Morphometry 
 The number of motoneurons labeled with HRP did not differ between groups. It is 
therefore unlikely that differences in measures of motoneuron morphology between 
groups were affected by potential differences in the number of motoneurons labeled with 
HRP. 
 Somata 
 Saporin injection resulted in the somata of contralateral motoneurons losing about 
20% of their cross-sectional area (Figure 6.3), consistent with the results of my previous 
studies (Fargo and Sengelaub, 2004a, 2004b). Treatment with either testosterone or DHT 
prevented this atrophy, but treatment with estradiol did not. These data indicate that the 
neuroprotective effect of testosterone treatment on soma size in this model is an 
androgenic effect. 
 Dendrites 
 The arbor per cell results mirror the soma size results (Figure 6.5). Saporin 
injection resulted in the loss of more than 65% of the dendritic arbor of contralateral 
motoneurons. Treatment with either testosterone or DHT prevented this, but treatment 
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with estradiol did not. Analysis of the radial distribution of dendritic length revealed that 
saporin injection resulted in the loss of dendritic length in every radial bin; furthermore, 
treatment with either testosterone or the non-aromatizable androgen DHT, but not 
estradiol, prevented these decreases in every radial bin (Figure 6.6). These data indicate 
that the neuroprotective effect of testosterone treatment on dendritic length in this model 
is an androgenic effect. 
 Dendritic extent displayed a pattern similar to overall dendritic length. Saporin 
injection decreased radial dendritic extent across all radial bins (Figure 6.7). Estradiol 
treatment was completely ineffective in preventing this. However DHT treatment did 
prevent this loss, and an examination of Figure 6.7 suggests that testosterone treatment 
was also partially effective, even though testosterone-treated animals were still 
significantly different from normal controls. These data suggest that androgen treatment 
exerts a protective effect on dendritic extent as well as dendritic length, while estradiol is 
ineffective by all of these measures. 
Is steroid neuroprotection exclusively androgenic in this system? 
 Because both testosterone and DHT were neuroprotective, while estradiol was 
not, the present results suggest that the neuroprotective effects of steroid treatment 
following saporin injection in this system are androgenic in nature. This is consistent with 
what is already known about adult morphological plasticity in the SNB. For example, 
following castration both testosterone and DHT are capable of maintaining SNB soma 
size (Forger et al., 1992; Verhovshek et al., 2000) and dendritic length (Verhovshek et al., 
2000). In contrast, estradiol replacement during adulthood fails to prevent castration-
induced atrophy of SNB motoneuron somata (Forger et al., 1992; Verhovshek et al., 
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2000) or dendrites (Verhovshek et al., 2000). Similarly, blockade of estradiol synthesis in 
intact adult males with the aromatase inhibitor fadrozole has no effect on SNB 
motoneuron morphology (Verhovshek et al., 2000). Furthermore, SNB motoneurons 
accumulate androgens, but not estradiol (Breedlove and Arnold, 1980; Breedlove and 
Arnold, 1983), and express high levels of 5α-reductase (Pozzi et al., 2003), the enzyme 
that converts testosterone into DHT. 
 However, estrogens have well-known trophic and neuroprotective effects (Cooke 
and Woolley, 2005; Garcia-Segura et al., 2001; Woolley and Cohen, 2002), and I think 
that it is still premature to completely rule out a role for estrogens in neuroprotection in 
the SNB. There are at least three reasons for this. First, the current experiment only tested 
the efficacy of estradiol, and there are of course other estrogens (such as estrone or 
estriol) that could potentially have neuroprotective effects. Second, although DHT is best 
known as a high-affinity ligand of the androgen receptor, recent reports from Robert 
Handa and colleagues indicate that DHT can be metabolized into steroids that act 
primarily via estrogen receptors (Lund et al., 2004; Pak et al., 2005). Finally, potential 
confounds exist in the design of the present experiment. Specifically, the dosage and 
route of administration for the androgens was different than for estradiol. While the 
amount of steroid in each group was chosen based on its efficacy in previous 
experiments, only testosterone had previously been used to prevent saporin-induced 
motoneuron atrophy, so I can’t really be sure that estradiol wouldn’t have been effective 
in this experiment had I used a higher dose. It is also possible that route of administration 
has something to do with steroid effectiveness in this preparation. In fact, one hypothesis 
as to why testosterone treatment is effective even though the implants used do not 
 127
produce supraphysiological levels of testosterone is that the implants eliminate natural 
diurnal fluctuations in serum testosterone levels. While estradiol levels do not fluctuate to 
the same extent as testosterone levels, and estradiol benzoate was used specifically to 
prolong exposure to estradiol throughout the day, it is highly doubtful that estradiol-
treated animals received hormone at the same constant rates as the androgen-treated 
animals. In fact, it is known that steroid esters in oil cause a spike in plasma hormone 
levels shortly after each daily injection (Smith et al., 1977). 
Conclusions 
 The results of this experiment indicate that testosterone’s neuroprotective effect 
following saporin injection is not mediated by its conversion to estradiol. Additionally, 
these data refute the hypothesis that testosterone’s protective effect on motoneuron 
morphology is mediated by its effects on the weight of the musculature, because DHT 
also is protective of morphology, even though the muscles of DHT-treated animals were 
actually smaller than those of normal controls. In summary, then, testosterone exerts its 
neuroprotective effect on SNB morphology by acting as an androgen, and doing so 
independently of its effects on muscle weight. 
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Chapter 7. 
 
General Discussion 
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  The purpose of this dissertation was to further explore the neuroprotective and 
neurotherapeutic effects of testosterone treatment following the partial loss of 
motoneurons. To that end, I performed experiments aimed at answering several important 
questions raised by my previous studies on this topic (see Chapter 1 for a review of my 
previous work). In this final chapter of the thesis I summarize the primary findings of my 
dissertation research, relate them to each other and to my previous studies, discuss 
broadly the significance of this work, and make proposals for future research. 
Summary of Primary Findings 
 Cell count data revealed that experimental manipulations used to deplete 
motoneuron populations were very effective. Unilateral saporin injection into the BC 
muscle alone killed approximately 40% of ipsilateral SNB motoneurons (Figure 3.2); and 
unilateral saporin injection into both the BC and LA muscles killed more than 60% of 
ipsilateral SNB motoneurons while leaving contralateral motoneuron numbers unchanged 
(Figure 6.3). These results are consistent with my previous studies (Fargo and Sengelaub, 
2004a, 2004b), and engender confidence that saporin injection was successful in killing 
only motoneurons projecting to the injected musculature. Similarly, unilateral ventral root 
avulsion killed more than 65% of ipsilateral SNB motoneurons, but no contralateral 
motoneurons (Figure 5.2). Most importantly, in no case did treatment with any gonadal 
steroid prevent motoneuron depletion. While this is in agreement with my previous 
studies (Fargo and Sengelaub, 2004a, 2004b), it needed to be confirmed in these studies, 
and in particular in the ventral root avulsion study, as steroid treatment is known to 
rescue motoneurons from death in some experimental paradigms (e.g., Ahlbom et al., 
2001; Hammond et al., 2001; Huppenbauer et al., 2005; Pike, 2001; Ramsden et al., 
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 2003). The importance of this finding is that it allows me to state that any potential 
beneficial effect of steroid treatment on remaining SNB motoneurons cannot be attributed 
to an attenuation of motoneuron depletion. 
 Muscle weight data was collected in every experiment. It was included in the 
experimental designs primarily as a manipulation check, but sometimes revealed 
interesting relationships. The first observation I would like to point out about muscle 
weight is that saporin injections had a reliably specific effect. Unilateral saporin injection 
into the BC and LA muscles reduced BC/LA weight only on the injected side (Figure 
6.2). This finding is in concert with my previous studies, in which saporin was also 
injected unilaterally into the BC and LA (Fargo and Sengelaub, 2004a, 2004b). 
Moreover, unilateral saporin injection into the BC muscle reduced the weight of the BC 
but not the (uninjected) ipsilateral LA muscle (Figure 3.1). Given that some researchers 
consider the LA muscle simply a compartment of the BC, this is a remarkable level of 
specificity. Similarly, unilateral ventral root avulsion resulted in marked atrophy of the 
ipsilateral BC/LA, but had no effect at all on contralateral BC/LA muscle weight (Figure 
5.1). 
 In contrast, steroid treatments had highly variable effects on muscle weight. This 
combination of a reliable depression of muscle weight and a variable effect of steroid 
treatment led to some interesting observations about the potential relationship between 
muscle weight and motoneuron morphology in steroid-treated animals. In all of the 
motoneuron depletion studies that I have conducted so far, testosterone treatment is only 
effective in protecting the morphology of remaining SNB motoneuron dendrites or 
somata when it is also effective in increasing the weight of the muscles to which those 
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 motoneurons project. For example, in contralateral saporin injection experiments, delayed 
treatment with exogenous testosterone both induced hypertrophy in the non-injected 
muscles and prevented dendritic retraction (Fargo and Sengelaub, 2004a), and immediate 
treatment with testosterone induced hypertrophy of the non-injected muscles and 
prevented both somatic and dendritic regression of SNB motoneurons (Fargo and 
Sengelaub, 2004b; Chapter 6, Figures 6.2, 6.4, and 6.6). In contrast, in the unilateral 
experiment described in Chapter 3, treatment with testosterone did not produce 
significant hypertrophy of the non-injected muscle (Figure 3.1), and also failed to prevent 
saporin-induced dendritic retraction (Figure 3.6). This pattern of results suggests the 
hypothesis that the ability of steroid treatment to protect dendritic morphology is 
dependent upon muscle hypertrophy. However, the results reported in Chapter 6, 
particularly with regard to the DHT-treated group, undermine this idea; DHT treatment 
actually decreased muscle weight slightly (Figure 6.2), while completely preventing 
saporin-induced dendritic retraction (Figure 6.6). The results reported in Chapter 6 also 
clearly suggest that androgens, but not estrogens, are capable of protecting SNB dendritic 
and somatic morphology following contralateral saporin-injection (Figures 6.4 and 6.6). 
 The results of the ventral root avulsion study (Chapter 5) are more difficult to 
interpret, primarily because VRA failed to cause somal or dendritic atrophy (Figures 5.3 
and 5.6). It is therefore impossible to reach a conclusion, based only on the results of that 
study, as to whether testosterone’s beneficial effects on the morphology of surviving 
motoneurons generalize to situations in which there is no exogenous neurotoxin 
introduced into the spinal cord. This study also produced another surprising result: 
testosterone treatment increased the weight of the denervated musculature above that of 
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 untreated VRA animals (Figure 5.1). This result directly contradicts the two previous 
reports in the literature that deal with testosterone treatment given to animals with a 
denervated BC/LA muscle complex (Burešová et al., 1972; Rand and Breedlove, 1992); 
both of these reports claimed that testosterone treatment had no effect at all on the weight 
of the denervated musculature. However, there were some differences between those 
experiments and the current work, which may explain the discrepancy in results; for 
example, Burešová et al. (1972) only recorded muscle weights for the LA, and Rand and 
Breedlove (1992) used local rather than systemic testosterone treatment. 
 The results presented in Chapter 4 demonstrate that saporin injection results in a 
number of electrophysiological changes, in addition to its effects on the morphology of 
neighboring motoneurons. Specifically, saporin injection decreased background activity, 
increased both response latency and activity duration, and depressed SNB motoneuron 
recruitment (Figures 4.5, 4.6, 4.7, and 4.8). More importantly, the results reported in 
Chapter 4 suggest that treatment with exogenous testosterone, in addition to maintaining 
normal motoneuron morphology, protects normal levels of SNB motoneuron recruitment 
(Figure 4.8). This effect was evident at high response magnitudes, making it all the more 
relevant for the normal functioning of the SNB neuromuscular system. 
What does it mean? 
 A few major conclusions can be drawn from the present work. First, given that 
testosterone can be metabolized into an estrogen, a major question arising from my 
earlier work was whether the neuroprotective effect of testosterone was an androgen 
effect, an estrogen effect, or both. The results reported in Chapter 6 clearly suggest that 
testosterone’s ability to protect SNB dendrites and somata following saporin injection is 
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 an androgen effect. While the non-aromatizable androgen DHT fully protected 
motoneuron morphology, estradiol had no beneficial effect at all (Figures 6.4 and 6.6). 
Second, these data indicate that steroid neuroprotection of dendrites and somata is not 
dependent on muscle hypertrophy, as DHT exerted a beneficial effect on motoneuron 
morphology without coincident hypertrophy of the target muscles (Figure 6.2). Third, the 
results reported in Chapter 4 suggest that testosterone treatment exerts a protective effect 
on the electrophysiological response properties of SNB motoneurons following saporin 
injection. Specifically, testosterone protects motoneuron recruitment at functionally 
relevant levels of response magnitude—an effect that appears in concert with, and 
possibly because of, testosterone’s protective effects on SNB motoneuron morphology 
(Figure 4.8). 
 These findings increase the potential usefulness of steroid treatment in 
neurodegenerative diseases or following traumatic injuries that lead to motoneuron 
depletion. DHT has much narrower physiological effects than its precursor, testosterone, 
and so would probably induce fewer off-target effects. As a concrete example from this 
thesis, DHT can be used in situations in which muscle hypertrophy is not a desirable 
outcome. In addition, the SNB recruitment data demonstrate that the anatomical benefits 
of steroid treatment are accompanied by a functional improvement in the 
electrophysiological response properties of the reflex pathway. Note that these same 
characteristics, in addition to making steroid treatment attractive as a potential therapy, 
increase the usefulness of this model for basic research in neuroprotection. 
 However, the work presented in this thesis also raises new questions as to the 
effectiveness of using steroids as therapeutic agents following partial motoneuron 
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 depletion. First, the experiment described in Chapter 3 indicates that testosterone 
treatment is completely ineffective in maintaining the dendritic length of LA-projecting 
motoneurons following saporin injection into the ipsilateral BC muscle (Figure 3.6). 
Second, the data presented in Chapter 5 leave me unable to draw a definite conclusion as 
to whether steroid treatment has a beneficial effect on motoneuron morphology when 
atrophy is induced by motoneuron loss unrelated to exogenous toxins. While the 
surprising results of these experiments do not rule out the potential utility of steroid 
treatment as a therapy, they do beg for more experiments. 
Future Directions 
 Future studies need to address the concerns raised by the results presented in 
Chapters 3 and 5. For example, the primary purpose of the experiment reported in 
Chapter 5 was to determine whether testosterone would be protective in a model of 
motoneuron depletion that did not involve the introduction of an exogenous neurotoxin 
into the spinal cord. But the chosen method, ventral root avulsion, did not induce atrophy 
in the surviving motoneurons. This surprising result left me unable to make a definitive 
statement regarding the main hypothesis. However, it raises questions as to why VRA did 
not induce atrophy in surviving motoneurons. The experiment leaves open several 
possible explanations for why saporin injection causes atrophy when VRA does not. For 
example, the atrophy may result from the direct action of saporin on the remaining 
motoneurons in the spinal cord, from the necrotic (as opposed to apoptotic) death induced 
by saporin, or from other possible sequelae of saporin injection, such as the death of 
primary afferents. By extension, then, testosterone may only have a protective effect in 
these limited instances. But these conclusions cannot be made on the basis of these data 
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 alone, because there may be other differences between motoneuron depletion by VRA 
and motoneuron depletion by saporin injection. For example, it could be that the longer, 
more progressive course of motoneuron death following VRA did not leave sufficient 
time for contralateral atrophy to manifest. Follow-up experiments could be done in which 
these variables are manipulated one at a time. Additional information could be gleaned 
from experiments that precisely determine the time course of VRA-induced motoneuron 
death in the SNB, then examine contralateral motoneuron morphology 4 weeks after 
depletion has reached the same levels that saporin causes within the first few days. Of 
course, it might be wise to consider simply trying another method to kill motoneurons 
unilaterally without introducing exogenous toxins—such as unilateral contusion. Further, 
consideration should be given to which method for killing motoneurons, saporin injection 
or VRA, represents a better model for neuronal depletion in the clinical setting. Various 
factors should be kept in mind in making such a determination. For example, many 
neurodegenerative diseases, with ALS, Parkinson’s disease, and Alzheimer’s diseases 
amongst them, result in neuronal depletion via apoptosis, which is induced by VRA but 
not saporin injection. Additionally, many lumbosacral spinal cord injuries are caused by 
shearing of the spinal roots, a situation much better modeled by VRA than by saporin 
injection. On the other hand, saporin injection causes motoneuron death by necrosis, 
which is common following contusion injuries of the spinal cord. 
 The results from Chapter 3 are similarly puzzling; why didn’t testosterone 
treatment prevent atrophy of LA-projecting motoneurons following saporin injection into 
the ipsilateral BC? This problem is difficult because the experimental setup in this study 
differed from previous studies in several ways (see pages 48 to 50), any of which could 
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 be responsible for the lack of a neuroprotective effect of testosterone. Initial follow-up 
experiments should focus on manipulating these variables one at a time. Specifically, I 
suggest an experiment in which saporin is injected unilaterally into both the BC and LA, 
then the morphology of contralateral LA-projecting motoneurons is measured in 
untreated and testosterone-treated animals. This experiment would determine whether the 
lack of a testosterone effect on dendrites in Chapter 3 was due to the fact that I measured 
morphology in LA-projecting instead of BC-projecting motoneurons. Depending on the 
results of that experiment, it might be profitable to perform an experiment in which 
saporin is injected unilaterally into the LA, and the morphology of ipsilateral BC-
projecting motoneurons is measured, again in both untreated and testosterone-treated 
animals. Assuming unilateral saporin injection into only the LA would be a strong 
enough manipulation to induce atrophy in BC-projecting motoneurons, this experiment 
would help determine whether the lack of a testosterone effect on dendrites in Chapter 3 
was related to the fact that morphometry was performed on motoneurons ipsilateral to the 
partial depletion. The results from this chapter reinforce the idea that the LA is not 
merely the dorsal aspect of the BC muscle. Indeed, LA-projecting SNB motoneurons are 
probably different from BC-projecting motoneurons in several very interesting ways that 
have yet to be determined. Delineating these differences could lead to years of exciting 
research possibilities in this system. 
 Of course, most motoneurons in the body are different from both BC- and LA-
projecting motoneurons in several known ways. First, SNB motoneurons are medially 
located and innervate a midline muscle complex. While this by no means makes them 
unique, it is the case that most motoneurons in the body are located in the lateral motor 
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 columns and innervate lateral muscle groups. Second, SNB motoneurons are uniquely 
sensitive to steroid manipulations. As reviewed in Chapter 1, SNB motoneurons depend 
on steroids for their survival, development, and adult maintenance. Therefore, a potential 
criticism of my work is that steroid treatments might not be neuroprotective in 
motoneuron populations that are not so uniquely steroid-dependent. For these reasons, a 
critical future direction for this research is to determine whether steroid treatment is 
similarly protective following motoneuron depletion in other motoneuron populations. In 
fact, such a project is currently ongoing in our laboratory. In this paradigm, motoneurons 
are depleted unilaterally by injection of saporin into a thigh muscle; then morphology is 
assessed in motoneurons projecting to a different thigh muscle, in both untreated and 
testosterone-treated animals. Preliminary unpublished results indicate that testosterone 
treatment does indeed preserve normal motoneuron morphology in this experimental 
design. 
 Of course, the experiments reported in Chapters 4 and 6, while more easily 
interpretable, also invite further studies. For example, the results from Chapter 4 suggest 
that testosterone exerts a protective effect on the function of the SNB by maintaining 
motoneuron recruitment at high response magnitudes. However, whether this has 
functional consequences in the awake, behaving animal is still an open question. Given 
that the primary purpose of the SNB neuromuscular system is to aid in successful 
copulation (Sachs, 1982), possible follow-up experiments could focus on copulatory 
behaviors and rates of impregnation. Similarly, the results of Chapter 6 support the 
hypothesis that testosterone’s protective effect is an androgen effect, but they are not 
completely conclusive. Recent reports suggest that DHT, while non-aromatizable, can be 
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 converted into a metabolite that acts via the beta estrogen receptor (Lund et al., 2004; Pak 
et al., 2005), raising the possibility, however remote, that testosterone and DHT are 
exerting estrogen effects after all. Therefore, follow-up experiments should involve using 
various antiandrogens and antiestrogens to selectively block steroid receptors in 
testosterone-treated animals. 
 In conclusion, the results of this dissertation work have shed some light on the use 
of testosterone as a neuroprotective/neurotherapeutic agent following partial motoneuron 
depletion, but as is so often the case, they raise more questions than they answer. Going 
forward, future work should focus on shoring up the arguments presented in this thesis 
and further delineating the parameters in which steroid treatment is an effective 
therapeutic strategy. 
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